{"content":"<li class=\"n-box-item date-title\" data-end=\"1530071999\" data-start=\"1529985600\" data-txt=\"Monday, December 23, 2019\">Tuesday, June 26, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3366411\" data-ts=\"1530052244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOLD\" target=\"_blank\">FOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366411-amicus-therapeuticsminus-10-on-missed-cma-in-europe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amicus Therapeutics -10% on missed CMA in Europe</a></h4><ul>   <li>Amicus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a>) is <font color='red'>9.9% lower</font> after hours after it announced updates to its development program for AT-GAA for Pompe Disease, which <a href=\"https://seekingalpha.com/pr/17202469-amicus-therapeutics-announces-european-regulatory-clinical-updates-gaa-pompe-disease\" target=\"_blank\">didn't get a Conditional Marketing Authorization</a>.</li>    <li>Meetings with the European Medicines' Agency's Scientific Advice Working Party suggested that efficacy data looked \"promising\" but insufficient for now.</li>    <li>SAWP was supportive of adding additional patient populations, which Amicus will pursue in 2019, to gather more data.</li>    <li>It will also be able to start Process Performance Qualification runs at commercial scale (1,000 liters).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366411\" data-linked=\"Amicus Therapeutics -10% on missed CMA in Europe\" data-tweet=\"$FOLD - Amicus Therapeutics -10% on missed CMA in Europe https://seekingalpha.com/news/3366411-amicus-therapeuticsminus-10-on-missed-cma-in-europe?source=tweet\" data-url=\"https://seekingalpha.com/news/3366411-amicus-therapeuticsminus-10-on-missed-cma-in-europe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366410\" data-ts=\"1530051415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRRX\" target=\"_blank\">DRRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366410-durectminus-10_9-ptieminus-75-after-failed-remoxy-vote\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Durect -10.9%, PTIE -75% after failed Remoxy vote</a></h4><ul>   <li>Durect (NASDAQ:<a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a>) is <font color='red'>10.9% lower</font> after hours following word that its partner, Pain Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a>), saw its Remoxy ER pain reliever <a href=\"https://seekingalpha.com/news/3366404-joint-fda-panel-votes-pain-therapeutics-remoxy-er\" target=\"_blank\">fail to secure approval</a> at a joint FDA committee meeting.</li>    <li>Pain Therapeutics has resumed trading <font color='red'>down 75%</font>. It had been halted today awaiting the results of the advisory committees.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366410\" data-linked=\"Durect -10.9%, PTIE -75% after failed Remoxy vote\" data-tweet=\"$DRRX $DRRX $SAVA - Durect -10.9%, PTIE -75% after failed Remoxy vote https://seekingalpha.com/news/3366410-durectminus-10_9-ptieminus-75-after-failed-remoxy-vote?source=tweet\" data-url=\"https://seekingalpha.com/news/3366410-durectminus-10_9-ptieminus-75-after-failed-remoxy-vote\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366409\" data-ts=\"1530051356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVAV\" target=\"_blank\">AVAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366409-aerovironmentminus-6-after-issuing-downside-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AeroVironment -6% after issuing downside revenue guidance</a></h4><ul>     <li>AeroVironment (NASDAQ:<a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a>) <font color='red'>-5.7%</font> after-hours despite reporting better than expected <a href=\"https://seekingalpha.com/news/3366363-aerovironment-beats-0_31-beats-revenue\" target=\"_blank\">FQ4 earnings</a> and revenues, as it guides FY 2019 revenues below analyst consensus.</li>     <li>AVAV sees FY 2019 EPS of $1.10-$1.40, which includes a $0.25-$0.26 litigation settlement and appears to not be comparable to the $1.00 analyst consensus estimate, and sees revenues of $290M-$310M vs. $337M consensus.</li>     <li>For Q4 2018, gross margin of $52.2M was down 9% Y/Y, primarily due to a $9.9M decrease in product margin; as a percentage of revenue, gross margin fell to 44% from 50% in the year-ago quarter.</li>     <li>AVAV says its funded backlog as of April 30 was $174.3M vs. $70.9M a year earlier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366409\" data-linked=\"AeroVironment -6% after issuing downside revenue guidance\" data-tweet=\"$AVAV - AeroVironment -6% after issuing downside revenue guidance https://seekingalpha.com/news/3366409-aerovironmentminus-6-after-issuing-downside-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3366409-aerovironmentminus-6-after-issuing-downside-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366396\" data-ts=\"1530048513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWE\" target=\"_blank\">WWE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366396-wweplus-8_1-on-new-u-s-flagship-deals-usa-fox\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WWE +8.1% on new U.S. flagship deals with USA, Fox</a></h4><ul>   <li>World Wrestling Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/WWE' title='World Wrestling Entertainment, Inc.'>WWE</a>) is <font color='green'>up 8.1%</font> after hours after announcing <a href=\"https://seekingalpha.com/pr/17202554-wwe-secures-multi-year-media-rights-deals-usa-network-fox-sports\" target=\"_blank\">new deals</a> with USA Network (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) and Fox Sports (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) for its flagship programs in the U.S.</li>    <li>The five-year deals cover <i>Monday Night Raw</i> (which will continue to air on USA) and <i>SmackDown Live</i> (to be distributed on Fox broadcast each Friday).</li>    <li>They increase the average annual value of WWE's U.S. distribution to 3.6 times its prior deal with NBCUniversal, the company says.</li>    <li>\"Substantial revenue growth\" from the new U.S. deals has WWE updating its guidance, targeting adjusted OIBDA of at least $200M for 2019, which covers just three months of the new deal rates.</li>    <li>It's holding a <a href=\"http://corporate.wwe.com/investors\" target=\"_blank\">conference call</a> tomorrow at 8 a.m. to discuss more long-term perspective on the key deals.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366396\" data-linked=\"WWE +8.1% on new U.S. flagship deals with USA, Fox\" data-tweet=\"$WWE $WWE $CMCSA - WWE +8.1% on new U.S. flagship deals with USA, Fox https://seekingalpha.com/news/3366396-wweplus-8_1-on-new-u-s-flagship-deals-usa-fox?source=tweet\" data-url=\"https://seekingalpha.com/news/3366396-wweplus-8_1-on-new-u-s-flagship-deals-usa-fox\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366395\" data-ts=\"1530048341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASCMA\" target=\"_blank\">ASCMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366395-after-hours-gainers-losers-06-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (06/26/2018)</a></h4><ul><li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/ASCMA' title='Ascent Capital Group, Inc.'>ASCMA</a>&nbsp;<font color='green'>+4%</font>. <a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>&nbsp;<font color='green'>+4%</font>. <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a>&nbsp;<font color='green'>+2.8%</font>. <a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a>&nbsp;<font color='green'>+2.1%</font>. <a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='green'>+1.9%</font>.</li><li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a>&nbsp;<font color='red'>-10.3%.&nbsp;</font><a href='https://seekingalpha.com/symbol/CNXM' title='CNX Midstream Partners LP'>CNXM</a>&nbsp;<font color='red'>-9.6%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a>&nbsp;<font color='red'>-7.1%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/SBLK' title='Star Bulk Carriers Corp.'>SBLK</a>&nbsp;<font color='red'>-6.9%.&nbsp;</font><a href='https://seekingalpha.com/symbol/VTR' title='Ventas Inc.'>VTR</a>&nbsp;<font color='red'>-4.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366395\" data-linked=\"After Hours Gainers / Losers (06/26/2018)\" data-tweet=\"$ASCMA $SCTY $RNG - After Hours Gainers / Losers (06/26/2018) https://seekingalpha.com/news/3366395-after-hours-gainers-losers-06-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366395-after-hours-gainers-losers-06-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366382\" data-ts=\"1530046186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRBT\" target=\"_blank\">IRBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366382-irobotplus-1_5-on-favorable-initial-patent-decision\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IRobot +1.5% on favorable initial patent decision</a></h4><ul><li>IRobot (NASDAQ:<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a>) <a href=\"https://seekingalpha.com/pr/17202526-irobot-announces-favorable-initial-determination-patent-dispute\" target=\"_blank\">announces</a> an initial determination recommending a limited exclusion order on bObsweep, Hoover, and Shenzhen ZhiYi Technology products that have infringed iRobot patents.</li><li>The recommendation is now before the ITC commissioners with a final determination expected by October 25. If the Commissioners agree, the exclusion order will go into effect upon publication of the final determination regardless of appeals.</li><li>IRobot shares are&nbsp;<font color='green'>up 1.5%</font>&nbsp;aftermarket to $76.53.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366382\" data-linked=\"IRobot +1.5% on favorable initial patent decision\" data-tweet=\"$IRBT - IRobot +1.5% on favorable initial patent decision https://seekingalpha.com/news/3366382-irobotplus-1_5-on-favorable-initial-patent-decision?source=tweet\" data-url=\"https://seekingalpha.com/news/3366382-irobotplus-1_5-on-favorable-initial-patent-decision\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366381\" data-ts=\"1530046162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNIT\" target=\"_blank\">UNIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366381-bloomberg-searchlight-offering-5_5m-uniti-group-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Searchlight offering 5.5M Uniti Group shares</a></h4><ul>   <li>Searchlight Capital Partners is offering 5.5M shares of its Uniti Group (NASDAQ:<a href='https://seekingalpha.com/symbol/UNIT' title='Uniti Group Inc.'>UNIT</a>) holdings, Bloomberg reports.</li>    <li>The firm will sell via UBS at $20.60-$20.80/share, according to the report.</li>    <li>That's a discount of 1.7%-2.7%.</li>    <li>Shares <font color='red'>declined 2%</font> today, adding on to a <font color='red'>5% drop</font> on Monday; they're flat after hours today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366381\" data-linked=\"Bloomberg: Searchlight offering 5.5M Uniti Group shares\" data-tweet=\"$UNIT - Bloomberg: Searchlight offering 5.5M Uniti Group shares https://seekingalpha.com/news/3366381-bloomberg-searchlight-offering-5_5m-uniti-group-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3366381-bloomberg-searchlight-offering-5_5m-uniti-group-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366375\" data-ts=\"1530045116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAC\" target=\"_blank\">DAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366375-danaos-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Danaos beats by $0.07, beats on revenue</a></h4><ul><li>Danaos (NYSE:<a href='https://seekingalpha.com/symbol/DAC' title='Danaos Corporation'>DAC</a>): Q1 EPS of $0.25 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $111.85M (+1.6% Y/Y) <font color='green'>beats by $7.87M</font>.</li><li>Shares <font color='green'>+11.11%</font>.</li><li><a href='https://seekingalpha.com/pr/17202538-danaos-corporation-reports-first-quarter-results-period-ended-march-31-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3366375\" data-linked=\"Danaos beats by $0.07, beats on revenue\" data-tweet=\"$DAC - Danaos beats by $0.07, beats on revenue https://seekingalpha.com/news/3366375-danaos-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3366375-danaos-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366374\" data-ts=\"1530044618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEAR\" target=\"_blank\">HEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366374-turtle-beachplus-1_5-on-new-esports-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turtle Beach +1.5% on new esports partnership</a></h4><ul><li>        Turtle Beach (NASDAQ:<a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a>) <a href=\"https://seekingalpha.com/pr/17202468-turtle-beach-partners-australian-esports-organization-tainted-minds-expand-global-esports\" target=\"_blank\">announces</a> a partnership with Australian esports organization Tainted Minds.</li><li>               Tainted Minds&rsquo; pro gaming teams and players will all use Turtle Beach&rsquo;s Elite Pro line of audio equipment.&nbsp;</li><li>               Tainted Minds competitive teams cover a variety of games including Call of Duty, Counter-Strike: Global Offensive, and Fortnite.&nbsp;</li><li>               Turtle Beach shares are&nbsp;<font color='green'>up 1.5%</font>&nbsp;aftermarket to $21.55.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366374\" data-linked=\"Turtle Beach +1.5% on new esports partnership\" data-tweet=\"$HEAR - Turtle Beach +1.5% on new esports partnership https://seekingalpha.com/news/3366374-turtle-beachplus-1_5-on-new-esports-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3366374-turtle-beachplus-1_5-on-new-esports-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366367\" data-ts=\"1530044240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366367-sonicminus-4_6-revenues-decline-miss-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic -4.6% as revenues decline, miss in Q3</a></h4><ul>   <li>Sonic (NASDAQ:<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a>) is <font color='red'>off 4.6%</font> in postmarket trading after <a href=\"https://seekingalpha.com/news/3366360-sonic-beats-0_03-misses-revenue\" target=\"_blank\">fiscal Q3 revenues</a> declined and missed, though it pointed to upward-trending same-store sales.</li>    <li>System same-store sales dipped 0.2% driven by declines at franchise drive-ins (company drive-ins ticked up 0.2%).</li>    <li>Adjusted EPS rose 21% and topped expectations; lower tax rates from tax reform added about $0.06/share of the adjusted EPS of $0.52.</li>    <li>&ldquo;Our third quarter same-store sales performance reflects a material improvement in trend, driven by ongoing initiatives to increase marketing reach, refresh our advertising creative and introduce relevant new products,\" says CEO Cliff Hudson.</li>    <li>For the full year, it now expects EPS of $1.45-$1.49 (in line with expectations for $1.47) -- excluding tax reform impact, a gain of 3-6% Y/Y.</li>    <li>In the forecast it expects system same-store sales down 1% or flat; free cash flow of about $60M; and drive-in-level margins of 15.3%-15.6% (depending on company same-store sales growth).</li>    <li><a href=\"https://edge.media-server.com/m6/p/an4go4xu\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>   <li><a href=\"https://seekingalpha.com/pr/17202471-sonic-reports-accelerating-store-sales-trend-third-fiscal-quarter-2018\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3366367\" data-linked=\"Sonic -4.6% as revenues decline, miss in Q3\" data-tweet=\"$SONC - Sonic -4.6% as revenues decline, miss in Q3 https://seekingalpha.com/news/3366367-sonicminus-4_6-revenues-decline-miss-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3366367-sonicminus-4_6-revenues-decline-miss-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366357\" data-ts=\"1530043023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366357-semiconductors-better-day-on-china-us-tech-clarity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semiconductors have better day on China-US tech clarity</a></h4><ul><li>Semiconductors have a better day, taking back some of yesterday&rsquo;s losses thanks to increasing clarity regarding US-China tech relations.</li><li>The improvement follows President Trump&rsquo;s <a href=\"https://www.reuters.com/article/us-usa-trade-china-investment/trump-says-cfius-can-protect-u-s-technology-from-chinese-acquisitions-idUSKBN1JM2PW?feedType=RSS&amp;feedName=businessNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FbusinessNews+%28Business+News%29\" target=\"_blank\">remarks</a> to reporters about the Committee on Foreign Investments in the US (CFIUS) protecting American technology from foreign companies.</li><li>Senate-passed legislation would strengthen the CFIUS authority to include reviewing transfers of minority interests in companies with critical tech and infrastructure. The legislation still needs to pass the House.</li><li>The Philadelphia Semiconductor Index is&nbsp;<font color='green'>up 0.33%</font>.</li><li>Top semiconductor movers include: AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+2.5%</font>), Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+2.6%</font>), Monolithic Power Systems (<a href='https://seekingalpha.com/symbol/MPWR' title='Monolithic Power Systems, Inc.'>MPWR</a> <font color='green'>+2%</font>), Texas Instruments (<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Inc.'>TXN</a> <font color='green'>+1.2%</font>), Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='green'>+1.7%</font>), and Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='green'>+1.7%</font>), Cypress Semiconductors (<a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a> <font color='green'>+1.1%</font>), and Maxim Integrated Products (<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a> <font color='green'>+1.6%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366190-micron-plus-2_1-percent-ubs-upgrade\" target=\"_blank\">Micron +2.1% after UBS upgrade</a> (June 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366191-intel-minus-1_8-percent-bernstein-moves-underperform-update\" target=\"_blank\">Intel -1.8% after Bernstein moves to Underperform (update)</a> (June 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366220-nvidia-1_4-percent-benchmark-new-buy-rating\" target=\"_blank\">Nvidia 1.4% after Benchmark New Buy rating</a> (June 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366357\" data-linked=\"Semiconductors have better day on China-US tech clarity\" data-tweet=\"$AMD $AMD $MU - Semiconductors have better day on China-US tech clarity https://seekingalpha.com/news/3366357-semiconductors-better-day-on-china-us-tech-clarity?source=tweet\" data-url=\"https://seekingalpha.com/news/3366357-semiconductors-better-day-on-china-us-tech-clarity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>115&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366355\" data-ts=\"1530042947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366355-financials-hurt-flatter-yield-curve-ebbing-consumer-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials hurt by flatter yield curve, ebbing consumer confidence</a></h4><ul><li><a href=\"https://www.bloomberg.com/news/articles/2018-06-26/banks-endure-record-streak-of-losses-as-yield-curve-flattens\" target=\"_blank\">The S&amp;P 500 Financials Index falls </a>for the 12th straight&nbsp;today, the longest losing streak ever.</li><li>The flattening yield curve and consumer confidence are both cause for concern. As well, investors are waiting for the second half of the Federal Reserve's stress test for financial institutions, which will determine how much in dividends they'll be able to pay and/or how many shares they'll be able to buy back.</li><li>The S&amp;P 500 Financials&nbsp;<font color='red'>-0.3%</font>&nbsp;late Tuesday.</li><li>Also, the Financial Select Sector SPDR EFT (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='red'>-0.3%</font>) has declined in the past seven trading days.</li><li>By late afternoon trading though, Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='green'>+0.4%</font>), Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='green'>+1%</font>), JPMorgan(<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='green'>+0.1%</font>), and Goldman Sachs (<a href='https://seekingalpha.com/symbol/GS' title='Goldman Sachs Group Inc.'>GS</a> <font color='green'>+0.1%</font>) were up.</li><li>Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='red'>-1%</font>) and Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color='red'>-0.1%</font>) are down as are most regional banks, including Fifth Third (<a href='https://seekingalpha.com/symbol/FITB' title='Fifth Third Bancorp'>FITB</a> <font color='red'>-1.5%</font>), KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color='red'>-1.2%</font>), and M&amp;T Bank (<a href='https://seekingalpha.com/symbol/MTB' title='M&T Bank Corporation'>MTB</a> <font color='red'>-1%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366263-consumer-confidence-drops-second-straight-month\" target=\"_blank\">Consumer confidence drops for second straight month</a> (June 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366355\" data-linked=\"Financials hurt by flatter yield curve, ebbing consumer confidence\" data-tweet=\"$BAC $XLF $BAC - Financials hurt by flatter yield curve, ebbing consumer confidence https://seekingalpha.com/news/3366355-financials-hurt-flatter-yield-curve-ebbing-consumer-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3366355-financials-hurt-flatter-yield-curve-ebbing-consumer-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366350\" data-ts=\"1530040467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366350-moffettnathanson-amazon-should-buy-cbs-to-take-on-netflix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoffettNathanson: Amazon should buy CBS to take on Netflix</a></h4><ul><li>        MoffettNathanson senior research analyst Michael Nathanson <a href=\"https://www.cnbc.com/2018/06/26/acquiring-cbs-would-be-a-logical-way-for-amazon-to-win-thestreaming.html\" target=\"_blank\">says</a> Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+1.8%</font>) should purchase a media company like CBS (<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> <font color='red'>-0.7%</font>) to expand its content library to rival Netflix.</li><li>               Nathanson says Amazon Prime Video&rsquo;s growth could prove slow if Amazon tries to build marketing while producing its own shows.&nbsp;</li><li>               CBS is currently in the middle of a court battle between National Amusements&rsquo; Shari Redstone and CBS CEO Les Moonves. An October 3 court date could decide the control of the company.&nbsp;</li><li>               Nathanson does doubt that CBS will be &ldquo;given their freedom from NAI&rsquo;s control&rdquo; but says &ldquo;an M&amp;A premium would quickly emerge&rdquo; if it did happen.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366350\" data-linked=\"MoffettNathanson: Amazon should buy CBS to take on Netflix\" data-tweet=\"$AMZN $AMZN $VIAC - MoffettNathanson: Amazon should buy CBS to take on Netflix https://seekingalpha.com/news/3366350-moffettnathanson-amazon-should-buy-cbs-to-take-on-netflix?source=tweet\" data-url=\"https://seekingalpha.com/news/3366350-moffettnathanson-amazon-should-buy-cbs-to-take-on-netflix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366348\" data-ts=\"1530039832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMI\" target=\"_blank\">KMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366348-kmi-upgraded-bernstein-trans-mountain-sale-start-of-something-good\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KMI upgraded at Bernstein as Trans Mountain sale &#39;start of something good&#39;</a></h4><ul>     <li>Kinder Morgan (<a href='https://seekingalpha.com/symbol/KMI' title='Kinder Morgan, Inc.'>KMI</a> <font color='green'>+2.2%</font>) moves higher after Bernstein <a href=\"https://www.barrons.com/articles/after-trans-mountain-sale-kinder-morgan-gets-a-boost-1530024343?mod=hp_RTA\" target=\"_blank\">upgrades</a> shares to Outperform from Market Perform with a $22 price target, up from $21, saying KMI's sale of the Trans Mountain pipeline to the Canadian government may \"finally be the start of something good\" for the company.</li>     <li>The sale will move KMI to 4.7x debt to EBITDA from 5.1x previously and remove a lot of uncertainty and capex, Bernstein's Jean Ann Salisbury says, hoping the company now will sell its enhanced oil recovery business for a good price to further reduce its leverage and sell other non-core assets.</li>     <li>With all that done,&nbsp;Salisbury tells KMI it can \"declare yourself the safe, defensive, 80% take or pay equivalent, 4.5x midstream company - what MLPs are supposed to be!\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3366348\" data-linked=\"KMI upgraded at Bernstein as Trans Mountain sale &#39;start of something good&#39;\" data-tweet=\"$KMI - KMI upgraded at Bernstein as Trans Mountain sale &#39;start of something good&#39; https://seekingalpha.com/news/3366348-kmi-upgraded-bernstein-trans-mountain-sale-start-of-something-good?source=tweet\" data-url=\"https://seekingalpha.com/news/3366348-kmi-upgraded-bernstein-trans-mountain-sale-start-of-something-good\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366345\" data-ts=\"1530039629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LINK\" target=\"_blank\">LINK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366345-technology-top-5-gainers-losers-of-3-00-pm-06-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 PM (06/26/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics'>LINK</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/TSRI' title='TSR, Inc.'>TSRI</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/CPAH' title='CounterPath Corporation'>CPAH</a> <font color='green'>+19%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/TAOP' title='Taoping Inc'>TAOP</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck Mobilisa, Inc.'>IDN</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366345\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 PM (06/26/2018)\" data-tweet=\"$LINK $LINK $TSRI - Technology - Top 5 Gainers / Losers as of 3:00 PM (06/26/2018) https://seekingalpha.com/news/3366345-technology-top-5-gainers-losers-of-3-00-pm-06-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366345-technology-top-5-gainers-losers-of-3-00-pm-06-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366342\" data-ts=\"1530038521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366342-musk-tweet-on-trucks-boosts-tesla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Musk tweet on trucks boosts Tesla</a></h4><ul><li>\"The Tesla [pickup] Truck will have dual motor all-wheel drive w/crazy torque &amp; a suspension that dynamically adjusts for load,\" <a href=\"https://twitter.com/elonmusk/status/1011678031801249793\" target=\"_blank\">tweets Elon Musk</a>. \"Those will be standard.\"</li><li>Already in the green on the session, Tesla (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='green'>+2.5%</font>) moves a bit higher.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366342\" data-linked=\"Musk tweet on trucks boosts Tesla\" data-tweet=\"$TSLA - Musk tweet on trucks boosts Tesla https://seekingalpha.com/news/3366342-musk-tweet-on-trucks-boosts-tesla?source=tweet\" data-url=\"https://seekingalpha.com/news/3366342-musk-tweet-on-trucks-boosts-tesla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>348&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366340\" data-ts=\"1530038272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPL\" target=\"_blank\">UPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366340-ultra-petroleumplus-7-avenue-capital-discloses-5_48-active-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultra Petroleum +7% as Avenue Capital discloses 5.48% active stake</a></h4><ul>     <li>Ultra Petroleum (<a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='green'>+7.8%</font>) pops after Avenue Capital Management <a href=\"https://www.sec.gov/Archives/edgar/data/1022646/000110465918042204/a18-16023_1sc13d.htm\" target=\"_blank\">discloses a 5.48% active stake</a>, saying it plans to engage in discussions on ways to maximize shareholder value.</li>     <li>Avenue Capital wants UPL to review opportunities including changes to capital structure, utilization of significant assets and/or possible strategic transactions, as well as potential changes in operations, management, board composition, governance, dividend  policy, corporate strategy and other areas.</li><li>UPL shares have plunged 76% YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366340\" data-linked=\"Ultra Petroleum +7% as Avenue Capital discloses 5.48% active stake\" data-tweet=\"$UPL $UPLC - Ultra Petroleum +7% as Avenue Capital discloses 5.48% active stake https://seekingalpha.com/news/3366340-ultra-petroleumplus-7-avenue-capital-discloses-5_48-active-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3366340-ultra-petroleumplus-7-avenue-capital-discloses-5_48-active-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366339\" data-ts=\"1530037614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPB\" target=\"_blank\">CPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366339-analysts-show-little-appetite-for-kraft-heinz-takeover-of-campbell-soup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts show little appetite for Kraft Heinz takeover of Campbell Soup</a></h4><ul>     <li>Campbell Soup (<a href='https://seekingalpha.com/symbol/CPB' title='Campbell Soup Company'>CPB</a> <font color='red'>-1.6%</font>) bubbled up 9% in yesterday's trade following a report that Kraft Heinz (<a href='https://seekingalpha.com/symbol/KHC' title='The Kraft Heinz Company'>KHC</a> <font color='red'>-0.4%</font>) is <a href=\"https://seekingalpha.com/news/3365917-report-kraft-heinz-interested-campbell-soup-buyout\" target=\"_blank\">interested in a takeover</a>, but analysts are out <a href=\"https://www.barrons.com/articles/throwing-cold-water-on-a-campbell-kraft-deal-1530036102?mod=hp_RTA\" target=\"_blank\">pouring cold water</a> on the likelihood of a deal.</li>     <li>&ldquo;<a href=\"https://www.marketwatch.com/story/campbell-soup-shares-soar-95-on-kraft-takeover-talk-but-analysts-dont-think-itll-happen-2018-06-25\" target=\"_blank\">We would be surprised</a> if Kraft Heinz wanted Campbell Soup, a company that does not solve Kraft Heinz&rsquo;s growth problems and is facing numerous internal challenges,&rdquo; J.P. Morgan analysts say.</li>     <li>&ldquo;While Campbell Soup no doubt brings significant synergies to Kraft Heinz, we do not believe it has the international presence and growing categories necessary to justify an acquisition by the company,&rdquo; according to analysts at Stifel.</li>     <li>If \"Kraft Heinz were to buy Campbell Soup, where sales growth has been lackluster for most of the last decade, this is unlikely to improve the company&rsquo;s reputation,\" Bernstein's Alexia Howard writes, adding that KHC would be better served by snapping up a consumer products company with more overseas exposure, such as Mondelez (NASDAQ:<a href='https://seekingalpha.com/symbol/MDLZ' title='Mondelēz International, Inc.'>MDLZ</a>), PepsiCo (NYSE:<a href='https://seekingalpha.com/symbol/PEP' title='PepsiCo Inc.'>PEP</a>) or Colgate-Palmolive (NYSE:<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Co.'>CL</a>).</li>     <li>On a similar vein, Piper Jaffray's Michael Lavery says CPB is not a good fit for KHC, which is seeking \"strong brands that can travel internationally,\" and that a play for CPB might disappoint for investors who believe KHC can \"dream bigger.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3366339\" data-linked=\"Analysts show little appetite for Kraft Heinz takeover of Campbell Soup\" data-tweet=\"$CPB $CPB $KHC - Analysts show little appetite for Kraft Heinz takeover of Campbell Soup https://seekingalpha.com/news/3366339-analysts-show-little-appetite-for-kraft-heinz-takeover-of-campbell-soup?source=tweet\" data-url=\"https://seekingalpha.com/news/3366339-analysts-show-little-appetite-for-kraft-heinz-takeover-of-campbell-soup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366335\" data-ts=\"1530036723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMASY\" target=\"_blank\">IMASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366335-eutelsat-backs-off-of-inmarsat-offer-imasyminus-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eutelsat backs off of Inmarsat offer; IMASY -15%</a></h4><ul>   <li>A day after confirming it was <a href=\"https://seekingalpha.com/news/3366022-inmarsat-plus-2_6-percent-report-eutelsat-takeover-interest\" target=\"_blank\">considering a bid for Inmarsat</a> (<a href='https://seekingalpha.com/symbol/IMASY' title='Inmarsat Plc. ADR'>OTCPK:IMASY</a>), Eutelsat (<a href='https://seekingalpha.com/symbol/EUTLY' title='Eutelsat Communications ADR'>OTCPK:EUTLY</a>) says it <a href=\"https://www.telegraph.co.uk/business/2018/06/26/eutelsat-abandons-inmarsat-bid-just-hours-admitting-interest/\" target=\"_blank\">won't make an offer</a>.</li>    <li>Inmarsat has <font color='red'>slid 14.7%</font> in OTC trading, while Eutelsat is <font color='green'>up 5.4%</font>.</li>    <li>The declaration clears a path for EchoStar (<a href=\"http://seekingalpha.com/symbol/SATS\" target=\"_blank\">SATS</a> <font color='red'>-1.1%</font>) in its own pursuit, though it's been <a href=\"https://seekingalpha.com/news/3362793-inmarsat-rejects-takeover-approach-echostar\" target=\"_blank\">rebuffed by Inmarsat</a> in its recent overtures.</li>    <li>Eutelsat won't make another run at Inmarsat unless it has Inmarsat board consent or another party makes a firm offer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366335\" data-linked=\"Eutelsat backs off of Inmarsat offer; IMASY -15%\" data-tweet=\"$IMASY $IMASY $EUTLY - Eutelsat backs off of Inmarsat offer; IMASY -15% https://seekingalpha.com/news/3366335-eutelsat-backs-off-of-inmarsat-offer-imasyminus-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3366335-eutelsat-backs-off-of-inmarsat-offer-imasyminus-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366333\" data-ts=\"1530036038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEXT\" target=\"_blank\">NEXT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366333-energy-materials-top-5-gainers-losers-of-2-00-pm-06-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/26/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NEXT' title='NextDecade Corporation'>NEXT</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/BWP' title='Boardwalk Pipeline Partners, LP'>BWP</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/OSN' title='Ossen Innovation Co., Ltd.'>OSN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SND' title='Smart Sand'>SND</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366333\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/26/2018)\" data-tweet=\"$NEXT $NEXT $AMRS - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/26/2018) https://seekingalpha.com/news/3366333-energy-materials-top-5-gainers-losers-of-2-00-pm-06-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366333-energy-materials-top-5-gainers-losers-of-2-00-pm-06-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366332\" data-ts=\"1530035809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAO\" target=\"_blank\">AKAO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366332-achaogen-down-20-after-fda-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achaogen down 20% after FDA approval</a></h4><ul><li>The approval for Zemdri was just for urinary tract infections, but not bloodstream infections. Also the label will exclude data from the Phase 3 \"Care\" trial.</li><li>Needham bull Alan Carr says the decision was as expected, and the label issue should have little impact on use of the drug.</li><li>He expects a July launch, with pricing to be inline with competitors at about $1K per day. Carr does have concern with the size of the&nbsp;carbapenem-resistant market, but&nbsp;Zemdri does have a differentiated mechanism of action.</li><li><a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a><font color='red'> -21.9%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3366209-achaogens-zemdri-antibiotic-approved-fda-urinary-tract-infections\" target=\"_blank\">Achaogen's Zemdri antibiotic approved by FDA for urinary tract infections</a> (June 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366332\" data-linked=\"Achaogen down 20% after FDA approval\" data-tweet=\"$AKAO - Achaogen down 20% after FDA approval https://seekingalpha.com/news/3366332-achaogen-down-20-after-fda-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3366332-achaogen-down-20-after-fda-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366330\" data-ts=\"1530034933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMCX\" target=\"_blank\">AMCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366330-amc-networksminus-2_5-goldman-goes-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMC Networks -2.5% as Goldman goes to Neutral</a></h4><ul>   <li>AMC Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/AMCX' title='AMC Networks Inc.'>AMCX</a>) is <font color='red'>off 2.5%</font> following Goldman Sachs' downgrade to Neutral.</li>    <li>The company faces slowing ad growth as The Walking Dead matures, to go along with ongoing affiliate fee pressures in pay TV for stand-alone content companies, analyst Drew Borst says. While M&amp;A is coming up more and more for such companies, AMC is a controlled company with a relatively limited library, crimping that potential catalyst. (h/t Bloomberg)</li>    <li>He's got a price target of $70, implying 11% upside from today's lower price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366330\" data-linked=\"AMC Networks -2.5% as Goldman goes to Neutral\" data-tweet=\"$AMCX - AMC Networks -2.5% as Goldman goes to Neutral https://seekingalpha.com/news/3366330-amc-networksminus-2_5-goldman-goes-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3366330-amc-networksminus-2_5-goldman-goes-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366327\" data-ts=\"1530033409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDC\" target=\"_blank\">CLDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366327-china-lending-doubles-on-heavy-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Lending more than doubles on heavy volume</a></h4><ul><li>China Lending (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a>) more than doubles (<font color='green'>+159%</font>) today with no specific news out.</li><li>About 7.78M shares changed hands by early afternoon trading, swamping its three-month daily average of 25,071 shares.</li><li>Currently trading at about $4.99, still down 20% from 52-week high of $6.24 on Oct. 13.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3361751-china-lending-soars-44-percent-still-50-percent-52-week-high\" target=\"_blank\">China Lending soars 44%, still about 50% off 52-week high</a> (June 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366327\" data-linked=\"China Lending more than doubles on heavy volume\" data-tweet=\"$CLDC - China Lending more than doubles on heavy volume https://seekingalpha.com/news/3366327-china-lending-doubles-on-heavy-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3366327-china-lending-doubles-on-heavy-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366320\" data-ts=\"1530032636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDC\" target=\"_blank\">CLDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366320-midday-gainers-losers-06-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (06/26/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+158%</font>. <a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a> <font color='green'>+44%</font>. <a href='https://seekingalpha.com/symbol/TSRI' title='TSR, Inc.'>TSRI</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics'>LINK</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a> <font color='green'>+28%</font>.  <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/LEE' title='Lee Enterprises, Incorporated'>LEE</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/ASCMA' title='Ascent Capital Group, Inc.'>ASCMA</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+22%</font>.<a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='green'>+18%</font>.</li>          <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/ATV' title='Acorn International, Inc.'>ATV</a>&nbsp;<font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a>&nbsp;<font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a>&nbsp;<font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a>&nbsp;<font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a>&nbsp;<font color='red'>-13%</font>.  <a href='https://seekingalpha.com/symbol/ICLK' title='iClick Interactive Asia Group Ltd.'>ICLK</a>&nbsp;<font color='red'>-13%.</font>&nbsp;<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>&nbsp;<font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a>&nbsp;<font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma'>LIFE</a>&nbsp;<font color='red'>-11%</font>.<a href='https://seekingalpha.com/symbol/SLNO' title='Soleno Therapeutics, Inc.'>SLNO</a>&nbsp;<font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366320\" data-linked=\"Midday Gainers / Losers (06/26/2018)\" data-tweet=\"$CLDC $CLDC $SPHS - Midday Gainers / Losers (06/26/2018) https://seekingalpha.com/news/3366320-midday-gainers-losers-06-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366320-midday-gainers-losers-06-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366321\" data-ts=\"1530032446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDC\" target=\"_blank\">CLDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366321-financials-top-gainers-losers-of-1-00-pm-06-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (06/26/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+160%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SAR' title='Saratoga Investment Corp'>SAR</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TREE' title='LendingTree, Inc.'>TREE</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366321\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (06/26/2018)\" data-tweet=\"$CLDC $CLDC $CCCR-OLD - Financials - Top Gainers / Losers as of 1:00 PM (06/26/2018) https://seekingalpha.com/news/3366321-financials-top-gainers-losers-of-1-00-pm-06-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366321-financials-top-gainers-losers-of-1-00-pm-06-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366319\" data-ts=\"1530032336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBOE\" target=\"_blank\">CBOE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366319-cboe-rises-after-jpmorgan-upgrades-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBOE rises after JPMorgan upgrades to neutral</a></h4><ul><li>Cboe Global Markets&nbsp; (NASDAQ:<a href='https://seekingalpha.com/symbol/CBOE' title='CBOE Holdings'>CBOE</a>)&nbsp;<font color='green'>+3.3%</font>&nbsp;after <a href=\"https://www.marketbeat.com/ratings/USA/latest/\" target=\"_blank\">JPMorgan upgrades t</a>o neutral from underweight.</li><li>CBOE rose as high as $107.66, its highest since May 18. Shares are down 13% year-to-date.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3361968-cboe-global-markets-volume-dips-last-years-busy-may\" target=\"_blank\">Cboe Global Markets volume dips from last year's busy May</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366319\" data-linked=\"CBOE rises after JPMorgan upgrades to neutral\" data-tweet=\"$CBOE - CBOE rises after JPMorgan upgrades to neutral https://seekingalpha.com/news/3366319-cboe-rises-after-jpmorgan-upgrades-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3366319-cboe-rises-after-jpmorgan-upgrades-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366316\" data-ts=\"1530031885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366316-crude-buyers-must-cut-all-iranian-oil-imports-november-u-s-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude buyers must cut all Iranian oil imports by November, U.S. says</a></h4><ul>     <li>U.S. WTI crude oil <a href=\"https://www.marketwatch.com/story/oil-prices-lifted-by-libya-supply-uncertainty-2018-06-26\" target=\"_blank\">climbs above $70/bbl</a> for the first time since May after the U.S. State Department says buyers of Iranian oil <a href=\"https://www.cnbc.com/2018/06/26/oil-buyers-must-cut-all-iranian-crude-imports-by-november-state-dept-.html\" target=\"_blank\">must wind down those purchases by November</a> or risk sanctions; WTI&nbsp;<font color='green'>+3.5%</font> at $70.50/bbl, Brent <font color='green'>+2.2%</font> at $76.39/bbl.</li>     <li>The Trump administration has not yet held talks with China, India or  Turkey about their purchases of Iranian crude, but it intends to  pressure them to entirely cut their imports under threat of sanctions, says a senior State Department official.</li>     <li>Buyers of Iranian crude had <a href=\"https://www.wsj.com/articles/u-s-signals-zero-tolerance-on-future-iran-oil-exports-1530028859\" target=\"_blank\">expected the U.S. would allow them time</a> to reduce oil imports over a much longer period by issuing sanctions waivers if significant efforts were made to cut their  purchases, based on previous comments from Trump administration officials as well as the Obama administration&rsquo;s earlier decision to wean the world off Iranian oil over several years.</li>     <li>Also supporting crude prices today are uncertainty over Libyan crude exports and doubts over OPEC&rsquo;s ability to increase production quickly enough to prevent a shortfall in global supplies.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/UBRT' title='Credit Suisse AxelaTrader 3x Long Brent Crude Oil ETN'>UBRT</a>, <a href='https://seekingalpha.com/symbol/ERYY' title='Direxion Daily Energy Bear 1x Shares ETF'>ERYY</a>, <a href='https://seekingalpha.com/symbol/DBRT' title='Credit Suisse AxelaTrader 3x Inverse Brent Crude Oil ETN'>DBRT</a>, <a href='https://seekingalpha.com/symbol/ERGF' title='iShares Edge MSCI Multifactor Energy ETF'>ERGF</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3366316\" data-linked=\"Crude buyers must cut all Iranian oil imports by November, U.S. says\" data-tweet=\"$USO $XLE $OIL - Crude buyers must cut all Iranian oil imports by November, U.S. says https://seekingalpha.com/news/3366316-crude-buyers-must-cut-all-iranian-oil-imports-november-u-s-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3366316-crude-buyers-must-cut-all-iranian-oil-imports-november-u-s-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>70&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366308\" data-ts=\"1530031460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRI\" target=\"_blank\">TSRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366308-tsr-jumps-31-on-request-to-pursue-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TSR jumps 31% on request to pursue sale</a></h4><ul><li>Joseph F. Hughes (former Chairman and CEO) and&nbsp;Winifred M. Hughes holding ~41.8% stake in the TSR (<a href='https://seekingalpha.com/symbol/TSRI' title='TSR, Inc.'>TSRI</a>&nbsp;<font color='green'>+31.8%</font>) request board to pursue a sale of the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366308\" data-linked=\"TSR jumps 31% on request to pursue sale\" data-tweet=\"$TSRI - TSR jumps 31% on request to pursue sale https://seekingalpha.com/news/3366308-tsr-jumps-31-on-request-to-pursue-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3366308-tsr-jumps-31-on-request-to-pursue-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366311\" data-ts=\"1530030927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWP\" target=\"_blank\">BWP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366311-boardwalk-pipelineplus-9-after-class-action-lawsuit-settlement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boardwalk Pipeline +9% after class action lawsuit settlement</a></h4><ul>     <li>Boardwalk Pipeline Partners (<a href='https://seekingalpha.com/symbol/BWP' title='Boardwalk Pipeline Partners, LP'>BWP</a> <font color='green'>+8.8%</font>) enjoys strong gains after <a href=\"https://www.sec.gov/Archives/edgar/data/1336047/000095010318007725/dp92542_8k.htm\" target=\"_blank\">confirming a settlement</a> in the class action litigation filed by TAM Capital Management and other investors in connection with the potential exercise of the call right for its common units.</li>     <li>In summary, if BWP general partner Loews (<a href='https://seekingalpha.com/symbol/L' title='Loews Corporation'>L</a> <font color='red'>-0.4%</font>) elects to exercise its call right no later than June 29, all claims relating to the litigation will be released and the litigation ended, subject to court approval.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366311\" data-linked=\"Boardwalk Pipeline +9% after class action lawsuit settlement\" data-tweet=\"$BWP $BWP $L - Boardwalk Pipeline +9% after class action lawsuit settlement https://seekingalpha.com/news/3366311-boardwalk-pipelineplus-9-after-class-action-lawsuit-settlement?source=tweet\" data-url=\"https://seekingalpha.com/news/3366311-boardwalk-pipelineplus-9-after-class-action-lawsuit-settlement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366310\" data-ts=\"1530030917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PF\" target=\"_blank\">PF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366310-pinnacle-foodsplus-3_5-on-report-of-advanced-conagra-buyout-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinnacle Foods +3.5% on report of advanced ConAgra buyout talks</a></h4><ul>   <li>Pinnacle Foods (NYSE:<a href='https://seekingalpha.com/symbol/PF' title='Pinnacle Foods'>PF</a>) is jumping, <font color='green'>up 3.5%</font>, on a CNBC report that ConAgra Brands (<a href=\"http://seekingalpha.com/symbol/CAG\" target=\"_blank\">CAG</a> <font color='red'>-0.2%</font>) is in <a href=\"https://www.cnbc.com/2018/06/26/conagra-brands-is-nearing-a-deal-to-acquire-pinnacle-foods.html\" target=\"_blank\">advanced talks to acquire the company</a>.</li>    <li>That deal would have a combined market cap of more than $23B and build the country's second-biggest frozen-food company, behind Nestle (<a href='https://seekingalpha.com/symbol/NSRGY' title='Nestle S.A. ADR'>OTCPK:NSRGY</a>).</li>    <li>The deal would be in cash and stock, sources told the network, and could come as soon as this week.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365629-pinnacle-food-plus-3-percent-amid-conagra-talk\" target=\"_blank\">Pinnacle Food +3% amid ConAgra talk</a> (Jun. 21 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358197-pinnacle-conagra-merger-speculation-picks\" target=\"_blank\">Pinnacle-ConAgra merger speculation picks up again</a> (May. 21 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366310\" data-linked=\"Pinnacle Foods +3.5% on report of advanced ConAgra buyout talks\" data-tweet=\"$PF $PF $NSRGY - Pinnacle Foods +3.5% on report of advanced ConAgra buyout talks https://seekingalpha.com/news/3366310-pinnacle-foodsplus-3_5-on-report-of-advanced-conagra-buyout-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3366310-pinnacle-foodsplus-3_5-on-report-of-advanced-conagra-buyout-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366305\" data-ts=\"1530029846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPOT\" target=\"_blank\">SPOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366305-spotify-hires-conde-nasts-ostroff-to-lead-content\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spotify hires Conde Nast&#39;s Ostroff to lead content</a></h4><ul>   <li>Spotify (<a href=\"http://seekingalpha.com/symbol/SPOT\" target=\"_blank\">SPOT</a> <font color='green'>+2.7%</font>) has named Conde Nast's Dawn Ostroff to take over as <a href=\"https://newsroom.spotify.com/2018-06-26/dawn-ostroff-named-chief-content-officer-spotify/\" target=\"_blank\">chief content officer</a>.</li>    <li>She'll have responsibility for all of the company's content partnerships across music, audio and video.</li>    <li>Ostroff has been president of Conde Nast Entertainment, where she's worked for seven years; she also developed several series as president of CW/UPN, including <i>Gossip Girl, Smallville, One Tree Hill</i> and <i>America's Next Top Model.</i></li>    <li>The move's effective at the end of July.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366234-spotify-plus-2_4-percent-barclays-joins-bulls\" target=\"_blank\">Spotify +2.4% as Barclays joins bulls</a> (Jun. 26 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366305\" data-linked=\"Spotify hires Conde Nast&#39;s Ostroff to lead content\" data-tweet=\"$SPOT - Spotify hires Conde Nast&#39;s Ostroff to lead content https://seekingalpha.com/news/3366305-spotify-hires-conde-nasts-ostroff-to-lead-content?source=tweet\" data-url=\"https://seekingalpha.com/news/3366305-spotify-hires-conde-nasts-ostroff-to-lead-content\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366297\" data-ts=\"1530028835\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAKD\" target=\"_blank\">NAKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366297-consumer-top-5-gainers-losers-of-12-00-pm-06-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/26/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/THRM' title='Gentherm Incorporated'>THRM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/TOUR' title='Tuniu Corporation'>TOUR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/HOME' title='At Home Group'>HOME</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366297\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/26/2018)\" data-tweet=\"$NAKD $NAKD $THRM - Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/26/2018) https://seekingalpha.com/news/3366297-consumer-top-5-gainers-losers-of-12-00-pm-06-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366297-consumer-top-5-gainers-losers-of-12-00-pm-06-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366295\" data-ts=\"1530028528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366295-apple-roundup-production-starts-on-iphone-6s-in-india-barclays-forecasts-june-q\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple roundup: Production starts on iPhone 6s in India, Barclays forecasts June Q</a></h4><ul><li>        Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) reportedly <a href=\"https://venturebeat.com/2018/06/26/apple-starts-indian-iphone-6s-production-and-plans-a-third-local-model/\" target=\"_blank\">starts production</a> on iPhone 6s devices in India with plans to produce another model in the country at a later date.</li><li>               Apple previously opened an Indian manufacturing facility to produce the iPhone SE for Indian customers.&nbsp;</li><li>                  The third model could be the iPhone 6s Plus.    </li><li>                  Apple needs to manufacture the phones in India to get around rising import taxes, which would help keep device prices down in a cost-conscious local market. &nbsp;   </li><li>               In other Apple news, Barclays is <a href=\"https://9to5mac.com/2018/06/26/barclays-iphone-sales-to-benefit-from-carrier-promos/\" target=\"_blank\">out with estimates</a> on short- and long-term Apple performance predictions.&nbsp;</li><li>               Analyst Mark Moskowitz says the June quarter will be influenced by iPhone carrier promotions in the US and China, foreign exchange rates, and the new free iCloud storage trial. Barclays expects the US dollar to depreciate 4% Y/Y for the June quarter.&nbsp;</li><li>               The analyst raises his EPS estimate 2% for FY18 to $12.25, but the FY19 EPS estimate drops 1% to $12.77.&nbsp;</li><li>               Firm keeps Apple at Neutral with a $175 price target.&nbsp;</li><li>                  Apple shares are&nbsp;<font color='green'>up 1.4%</font>&nbsp;to $184.67.    &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366295\" data-linked=\"Apple roundup: Production starts on iPhone 6s in India, Barclays forecasts June Q\" data-tweet=\"$AAPL - Apple roundup: Production starts on iPhone 6s in India, Barclays forecasts June Q https://seekingalpha.com/news/3366295-apple-roundup-production-starts-on-iphone-6s-in-india-barclays-forecasts-june-q?source=tweet\" data-url=\"https://seekingalpha.com/news/3366295-apple-roundup-production-starts-on-iphone-6s-in-india-barclays-forecasts-june-q\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>121&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366288\" data-ts=\"1530026282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCKT\" target=\"_blank\">RCKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366288-rocket-pharmaceuticals-files-300m-mixed-securities-shelf\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rocket Pharmaceuticals files $300M mixed securities shelf</a></h4><ul><li>        Rocket Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RCKT' title='Rocket Pharmaceuticals, Inc.'>RCKT</a>) <a href=\"https://seekingalpha.com/filing/4078310\" target=\"_blank\">files</a> for a $300M mixed securities shelf offering.</li><li>               Rocket shares are&nbsp;<font color='red'>down 0.4%</font>&nbsp;to $20.52.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366288\" data-linked=\"Rocket Pharmaceuticals files $300M mixed securities shelf\" data-tweet=\"$RCKT - Rocket Pharmaceuticals files $300M mixed securities shelf https://seekingalpha.com/news/3366288-rocket-pharmaceuticals-files-300m-mixed-securities-shelf?source=tweet\" data-url=\"https://seekingalpha.com/news/3366288-rocket-pharmaceuticals-files-300m-mixed-securities-shelf\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366287\" data-ts=\"1530026214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMNY\" target=\"_blank\">HMNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366287-moviepass-parentminus-13_2-amc-subscriptions-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoviePass parent -13.2% as AMC subscriptions launch</a></h4><ul>   <li>MoviePass parent Helios &amp; Matheson (NASDAQ:<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a>) is <font color='red'>off 13.2%</font> today with the official launch of AMC Theatres' (<a href=\"http://seekingalpha.com/symbol/AMC\" target=\"_blank\">AMC</a> <font color='red'>-1.8%</font>) <a href=\"https://variety.com/2018/film/news/amc-theatres-strong-response-subscription-plan-1202857633/\" target=\"_blank\">monthly subscription plan</a>.</li>    <li>AMC Stubs A-List is \"simple and sustainable,\" the theater chain says, in a shot at MoviePass plans criticized on the Street for being too cheap to survive. AMC's plan allows members to see <a href=\"https://seekingalpha.com/news/3365195-amc-expands-movie-subscription-service\" target=\"_blank\">three movies a week</a> at AMC locations, regardless of format, for $19.95/month.</li>    <li>The new AMC plan has seen \"overwhelmingly positive response\" since the company announced it, says CEO Adam Aron.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366287\" data-linked=\"MoviePass parent -13.2% as AMC subscriptions launch\" data-tweet=\"$HMNY $HMNY $AMC - MoviePass parent -13.2% as AMC subscriptions launch https://seekingalpha.com/news/3366287-moviepass-parentminus-13_2-amc-subscriptions-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/3366287-moviepass-parentminus-13_2-amc-subscriptions-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>137&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366284\" data-ts=\"1530025690\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLDB\" target=\"_blank\">SLDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366284-solid-biosciences-drops-11_5-on-retirement-of-co-founder-and-president\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid Biosciences drops 11.5% on retirement of co-founder and president</a></h4><ul><li>        Solid Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a>) <a href=\"https://seekingalpha.com/pr/17201387-solid-biosciences-welcomes-industry-expert-dr-martin-freed-board-directors\" target=\"_blank\">announces</a> that Dr. Martin Freed has joined the board. He most recently served as the CMO of Civitas Therapeutics, which was acquired by Acorda in 2014.</li><li>               Solid co-founder, director, and president Gilad Hayeem has retired from his role as president and the board to &ldquo;pursue other activities.&rdquo;&nbsp;</li><li>               Co-Founder and CEO Ilan Ganot assumes the role of president. &nbsp;&nbsp;</li><li>               Solid Biosciences shares are&nbsp;<font color='red'>down 11.5%</font>&nbsp;to $38.20.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366284\" data-linked=\"Solid Biosciences drops 11.5% on retirement of co-founder and president\" data-tweet=\"$SLDB - Solid Biosciences drops 11.5% on retirement of co-founder and president https://seekingalpha.com/news/3366284-solid-biosciences-drops-11_5-on-retirement-of-co-founder-and-president?source=tweet\" data-url=\"https://seekingalpha.com/news/3366284-solid-biosciences-drops-11_5-on-retirement-of-co-founder-and-president\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366283\" data-ts=\"1530025635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUY\" target=\"_blank\">AUY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366283-yamana-gold-starts-commercial-production-argentinas-cerro-moro-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yamana Gold starts commercial production at Argentina&#39;s Cerro Moro mine</a></h4><ul>     <li>Yamana Gold (<a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color='red'>-2%</font>) says it has <a href=\"https://seekingalpha.com/pr/17201565-yamana-gold-declares-commercial-production-cerro-moro\" target=\"_blank\">started commercial production</a> at its Cerro Moro gold and silver mine in Argentina.</li>     <li>AUY expects Cerro Moro to \"generate a disproportionate amount of cash flow and free cash flow relative to the comparatively small-scale nature of the operation.\"</li>     <li>When production <a href=\"http://www.mining.com/yamana-kicks-off-production-argentinas-gold-silver-mine/\" target=\"_blank\">ramps up</a>, Cerro Moro is expected to yield 85K oz. of gold and 3.75M oz. of silver this year, nearly all of it in H2, rising to 125K gold oz. and 6M silver oz. in 2019, which should help AUY&rsquo;s plans  to ramp up gold production by 20% and its silver production by 200% next year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366283\" data-linked=\"Yamana Gold starts commercial production at Argentina&#39;s Cerro Moro mine\" data-tweet=\"$AUY - Yamana Gold starts commercial production at Argentina&#39;s Cerro Moro mine https://seekingalpha.com/news/3366283-yamana-gold-starts-commercial-production-argentinas-cerro-moro-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3366283-yamana-gold-starts-commercial-production-argentinas-cerro-moro-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366282\" data-ts=\"1530025579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTN\" target=\"_blank\">GTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366282-gray-television-up-another-10-analysts-praise-raycom-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gray Television up another 10% as analysts praise Raycom deal</a></h4><ul>   <li>Gray Television (NYSE:<a href='https://seekingalpha.com/symbol/GTN' title='Gray Television, Inc.'>GTN</a>) is <font color='green'>up 10.4%</font>, another double digit gain following yesterday's 16% rise on the heels of a <a href=\"https://seekingalpha.com/news/3365956-gray-television-buying-raycom-media-3_6b\" target=\"_blank\">deal to buy Raycom Media</a> for $3.6B.</li>    <li>Wells Fargo's Marci Ryvicker notes a deal \"as clean as they come,\" filled with positives including culture fit and a focus on high-quality news. It's the \"most accretive deal we have seen in this space, she writes; she has a Street-high price target of $28 on Gray, still 70% upside from today's sharply higher price. (h/t Bloomberg)</li>    <li>Barrington's James Goss says Raycom is arguably Gray's closest comparable, so the deal leverages operating advantages and doubles Gray's footprint. He has a $19 price target.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366282\" data-linked=\"Gray Television up another 10% as analysts praise Raycom deal\" data-tweet=\"$GTN - Gray Television up another 10% as analysts praise Raycom deal https://seekingalpha.com/news/3366282-gray-television-up-another-10-analysts-praise-raycom-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3366282-gray-television-up-another-10-analysts-praise-raycom-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366279\" data-ts=\"1530025236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHV\" target=\"_blank\">ACHV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366279-healthcare-top-5-gainers-losers-of-11-00-06-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/26/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/GNPX' title='Genprex, Inc'>GNPX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> <font color='red'>-11%</font>. COOL <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366279\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/26/2018)\" data-tweet=\"$ACHV $ACHV $GNPX - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/26/2018) https://seekingalpha.com/news/3366279-healthcare-top-5-gainers-losers-of-11-00-06-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366279-healthcare-top-5-gainers-losers-of-11-00-06-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366277\" data-ts=\"1530024818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KOS\" target=\"_blank\">KOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366277-kosmos-energyminus-6-suriname-well-fails-to-hit-paydirt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kosmos Energy -6% as Suriname well fails to hit paydirt</a></h4><ul>     <li>Kosmos Energy (<a href='https://seekingalpha.com/symbol/KOS' title='Kosmos Energy'>KOS</a> <font color='red'>-5.8%</font>) is sharply lower after <a href=\"https://seekingalpha.com/pr/17201173-kosmos-energy-provides-update-exploration-drilling-program-offshore-suriname\" target=\"_blank\">coming up dry</a> at its latest exploration well offshore Suriname.</li>     <li>KOS says its Anapai-1A well in Block 45 is being plugged and abandoned after failing to find hydrocarbons after being drilled to a total depth of 4,556 meters.</li>     <li>&ldquo;We are still in the early stages of exploring this newly emerging basin and our forward drilling program remains unchanged given the independent nature of the prospects,\" the company says.</li>     <li>KOS holds rights in the Block 45 and Block 42 contract areas under production sharing contracts with Suriname's government; KOS is the exploration operator of Block 45 and is joined by its 50-50 partner Chevron (NYSE:<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a>), and KOS is the       exploration operator of Block 42 and is joined by partners CVX and Hess, each with 33.33%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366277\" data-linked=\"Kosmos Energy -6% as Suriname well fails to hit paydirt\" data-tweet=\"$KOS $KOS $CVX - Kosmos Energy -6% as Suriname well fails to hit paydirt https://seekingalpha.com/news/3366277-kosmos-energyminus-6-suriname-well-fails-to-hit-paydirt?source=tweet\" data-url=\"https://seekingalpha.com/news/3366277-kosmos-energyminus-6-suriname-well-fails-to-hit-paydirt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366276\" data-ts=\"1530024767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNPX\" target=\"_blank\">GNPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366276-genprex-up-16-selects-clinic-for-oncoprex\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genprex up 16% as it selects clinic for Oncoprex</a></h4><ul><li>The company has chosen 4Clinics Group Sprl to provide support for the clinical development of Oncoprex for the treatment of non-small cell lung cancer.</li><li>COO Julien Pham: \"This is an important step forward for Genprex (<a href='https://seekingalpha.com/symbol/GNPX' title='Genprex, Inc'>GNPX</a> <font color='green'>+16.5%</font>) as we expand the scope of the Oncoprex clinical development program to build on the encouraging data we've compiled to date.\"</li><li>Source: <a href=\"https://seekingalpha.com/pr/17201545-genprex-selects-4clinics-provide-clinical-regulatory-support-oncoprex-development-program\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3366276\" data-linked=\"Genprex up 16% as it selects clinic for Oncoprex\" data-tweet=\"$GNPX - Genprex up 16% as it selects clinic for Oncoprex https://seekingalpha.com/news/3366276-genprex-up-16-selects-clinic-for-oncoprex?source=tweet\" data-url=\"https://seekingalpha.com/news/3366276-genprex-up-16-selects-clinic-for-oncoprex\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366265\" data-ts=\"1530024737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHN\" target=\"_blank\">SCHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366265-on-schnitzer-steels-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Schnitzer Steel&#39;s Q3 results</a></h4><ul><li>Schnitzer Steel Industries (<a href='https://seekingalpha.com/symbol/SCHN' title='Schnitzer Steel Industries, Inc.'>SCHN</a> <font color='red'>-0.1%</font>) reported Q3 revenue growth of 36.7% Y/Y to $652.42M. Segment revenue: Auto &amp; metal recycling $529.6M (+37% Y/Y) and Cascade steel &amp; scarp $130M (+35% Y/Y).</li><li>Q3 Overall operating margin<font color='green'> improved by 384 bps</font>&nbsp;to 7.8%. Segment operating margin: AMR&nbsp;<font color='green'>improved by 272 bps</font>&nbsp;to 10.4% and CSS&nbsp;<font color='green'>improved by 709 bps</font>&nbsp;to 8.3%.</li><li>Auto &amp; metal recycling results: Ferrous revenue $364M (+54% Y/Y) with a 19% Y/Y increase in volumes to 983k LT at an avg. sale price of $337 per LT (+31% Y/Y). Non-ferrous revenue $127 (+12% Y/Y) with 3% Y/Y decrease in volumes to 146M LB at an avg. sales price of $0.74 per LB (+14% Y/Y). Cars purchased for retail 109k (+1% Y/Y).</li><li>Cascade steel &amp; scrap results: Steel revenue $104M (+27% Y/Y) with finished steel volumes at 140k ST (-1% Y/Y) at an avg. price of $703 per ST (+29% Y/Y). Recycling revenue $26M (+85% Y/Y).</li><li>Company generated operating cash flow of $64M driven by increased profitability.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366213-schnitzer-steel-beats-0_08-beats-revenue\" target=\"_blank\">Schnitzer Steel beats by $0.08, beats on revenue</a> (June 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366265\" data-linked=\"More on Schnitzer Steel&#39;s Q3 results\" data-tweet=\"$SCHN - More on Schnitzer Steel&#39;s Q3 results https://seekingalpha.com/news/3366265-on-schnitzer-steels-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3366265-on-schnitzer-steels-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366275\" data-ts=\"1530024527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAR\" target=\"_blank\">CAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366275-hertz-avis-tumble-on-dour-morgan-stanley-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz, Avis tumble on dour Morgan Stanley note</a></h4><ul><li>Both companies are facing secular and cyclical headwinds, and will struggle to raise prices enough to overcome rising fleet depreciation costs, says analyst Adam Jonas.</li><li>He resumes coverage of Avis (<a href='https://seekingalpha.com/symbol/CAR' title='Avis Budget Group, Inc.'>CAR</a> <font color='red'>-8.8%</font>) with an Underweight rating and Street-low price target of $30 (about 30% downside from Monday's close). Hertz (<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='red'>-10.8%</font>) continues at Underweight with price target hiked to $15 from $13 (also about 30% downside from Monday close).</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3366275\" data-linked=\"Hertz, Avis tumble on dour Morgan Stanley note\" data-tweet=\"$CAR $CAR $HTZ - Hertz, Avis tumble on dour Morgan Stanley note https://seekingalpha.com/news/3366275-hertz-avis-tumble-on-dour-morgan-stanley-note?source=tweet\" data-url=\"https://seekingalpha.com/news/3366275-hertz-avis-tumble-on-dour-morgan-stanley-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366273\" data-ts=\"1530024265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIRI\" target=\"_blank\">SIRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366273-sirius-xmminus-2_3-barclays-cuts-to-underweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sirius XM -2.3% as Barclays cuts to Underweight</a></h4><ul>   <li>Sirius XM (NASDAQ:<a href='https://seekingalpha.com/symbol/SIRI' title='Sirius XM Holdings Inc.'>SIRI</a>) is headed for its sixth down day in a row, <font color='red'>-2.3%</font>, after a downgrade to Underweight at Barclays.</li>    <li>The company, in a more mature growth phase, is facing tougher margin expansion with higher competitive pressures, Kannan Venkateshwar writes. It's one of the most expensive stocks in media, with price to free cash flow around 21x for 2019. (h/t Bloomberg)</li>    <li>Shares have also been on a run in 2018, <font color='green'>up 31.7%</font>.</li>    <li>The firm has a price target of $5, implying 28% downside from current pricing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366273\" data-linked=\"Sirius XM -2.3% as Barclays cuts to Underweight\" data-tweet=\"$SIRI - Sirius XM -2.3% as Barclays cuts to Underweight https://seekingalpha.com/news/3366273-sirius-xmminus-2_3-barclays-cuts-to-underweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3366273-sirius-xmminus-2_3-barclays-cuts-to-underweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366270\" data-ts=\"1530023940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOME\" target=\"_blank\">HOME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366270-home-groupplus-7_2-on-morgan-stanley-upgrade-29-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">At Home Group +7.2% on Morgan Stanley upgrade, 29% upside</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Upgrades+At+Home+Group+%28HOME%29+to+Overweight/14341583.html\" target=\"_blank\">upgrades</a> At Home Group (NASDAQ:<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group'>HOME</a>) from Equal Weight to Overweight and raises the price target from $35 to $47, a 29% upside to yesterday&rsquo;s close.</li><li>               At Home Group shares are&nbsp;<font color='green'>up 7.2%</font>&nbsp;to $38.98.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366270\" data-linked=\"At Home Group +7.2% on Morgan Stanley upgrade, 29% upside\" data-tweet=\"$HOME - At Home Group +7.2% on Morgan Stanley upgrade, 29% upside https://seekingalpha.com/news/3366270-home-groupplus-7_2-on-morgan-stanley-upgrade-29-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3366270-home-groupplus-7_2-on-morgan-stanley-upgrade-29-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366266\" data-ts=\"1530023566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INCY\" target=\"_blank\">INCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366266-incyteminus-6_3-on-rbc-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Incyte -6.3% on RBC downgrade</a></h4><ul><li>        RBC Capital <a href=\"https://www.streetinsider.com/Analyst+PT+Change/RBC+Capital+Downgrades+Incyte+%28INCY%29+to+Sector+Perform/14341623.html\" target=\"_blank\">downgrades</a> Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) from Outperform to Sector Weight.</li><li>               Incyte shares are&nbsp;<font color='red'>down 6.3%</font>&nbsp;to $67.18.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366266\" data-linked=\"Incyte -6.3% on RBC downgrade\" data-tweet=\"$INCY - Incyte -6.3% on RBC downgrade https://seekingalpha.com/news/3366266-incyteminus-6_3-on-rbc-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3366266-incyteminus-6_3-on-rbc-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366264\" data-ts=\"1530023203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DMLRY\" target=\"_blank\">DMLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366264-daimler-ag-selects-xilinx-for-ai-in-car-system\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daimler AG selects Xilinx for AI in-car system</a></h4><ul><li>        Daimler AG (<a href='https://seekingalpha.com/symbol/DMLRY' title='Daimler AG ADR'>OTCPK:DMLRY</a>) <a href=\"https://seekingalpha.com/pr/17201841-daimler-ag-selects-xilinx-drive-artificial-intelligence-based-automotive-applications\" target=\"_blank\">selects</a> Xilinx (NASDAQ:<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a>) to collaborate on an in-car system using AI processing in an automotive application.</li><li>               The scalable solution will be powered by a Xilinx automotive platform consisting of SoC devices and AI acceleration software for high performance, low latency, and power efficiency.&nbsp;</li><li>               Xilinx shares are&nbsp;<font color='green'>up 0.6%</font>&nbsp;to $65.90.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366264\" data-linked=\"Daimler AG selects Xilinx for AI in-car system\" data-tweet=\"$DMLRY $DMLRY $XLNX - Daimler AG selects Xilinx for AI in-car system https://seekingalpha.com/news/3366264-daimler-ag-selects-xilinx-for-ai-in-car-system?source=tweet\" data-url=\"https://seekingalpha.com/news/3366264-daimler-ag-selects-xilinx-for-ai-in-car-system\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366259\" data-ts=\"1530022634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366259-sibanye-stillwaterminus-10-another-miner-dies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sibanye-Stillwater -10% as another miner dies</a></h4><ul>     <li>Sibanye-Stillwater (<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='red'>-9.9%</font>) plunges after suffering <a href=\"https://www.miningreview.com/sibanye-stillwater-suffers-another-employee-fatality/\" target=\"_blank\">another employee fatality</a>, the miner's 21st this year.</li>     <li>The latest accident occurred at its Khomanani mine at the Driefontein operation in South Africa, when an employee entered a scraper path and was fatally injured.</li>     <li>A key member of South Africa's parliament says the company should be <a href=\"https://www.enca.com/south-africa/another-fatality-in-sibanye-mine-accident\" target=\"_blank\">placed under curatorship</a> and potentially lose its&nbsp;operating license.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366259\" data-linked=\"Sibanye-Stillwater -10% as another miner dies\" data-tweet=\"$SBGL - Sibanye-Stillwater -10% as another miner dies https://seekingalpha.com/news/3366259-sibanye-stillwaterminus-10-another-miner-dies?source=tweet\" data-url=\"https://seekingalpha.com/news/3366259-sibanye-stillwaterminus-10-another-miner-dies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366253\" data-ts=\"1530021699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366253-morgan-stanley-analyst-thinks-new-iphones-will-start-699\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley analyst thinks new iPhones will start at $699</a></h4><ul><li>        Morgan Stanley analyst Katy Huberty <a href=\"https://bgr.com/2018/06/26/iphone-x-plus-release-date-right-price/\" target=\"_blank\">offers pricing estimates</a> for the three new Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhones expected to release later this year.</li><li>                  The 5.8-inch iPhone X successor will start at $899 ($100 less than last year&rsquo;s model) while the 6.5-inch phablet version will start at $999. Pricing will go over $1K for both of these OLED models with more storage with the higher-end model costing $1,149.    </li><li>               The lower-cost 6.1-inch iPhone with an LCD screen will start between $699 and $769.&nbsp;</li><li>               Huberty expects iPhone ASP to either decline 2% in FY19 or grow 2%, depending on the final pricing particularly on the cheapest phone.&nbsp;</li><li>               Apple shares are&nbsp;<font color='green'>up 1.1%</font>&nbsp;to $184.17.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366253\" data-linked=\"Morgan Stanley analyst thinks new iPhones will start at $699\" data-tweet=\"$AAPL - Morgan Stanley analyst thinks new iPhones will start at $699 https://seekingalpha.com/news/3366253-morgan-stanley-analyst-thinks-new-iphones-will-start-699?source=tweet\" data-url=\"https://seekingalpha.com/news/3366253-morgan-stanley-analyst-thinks-new-iphones-will-start-699\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366249\" data-ts=\"1530021380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366249-reduction-coming-to-aggregate-ge-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reduction coming to aggregate GE dividend</a></h4><ul><li>\"Given the typically lower payout ratios in the health-care industry this [healthcare spinoff] will likely lead to a reduction in the aggregate GE dividend at that time,\" CEO John Flannery <a href=\"https://www.cnbc.com/2018/06/26/ceo-flannery-says-healthcare-spinoff-will-likely-lead-to-a-reduction-.html?__source=yahoo%7Cfinance%7Cheadline%7Cstory%7C&amp;par=yahoo&amp;yptr=yahoo\" target=\"_blank\">said</a> on the company's investor call.</li><li>The spinoff is expected to be completed within 12 to 18 months.</li><li>General Electric's (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='green'>+7.5%</font>) current dividend yield is 3.8%, higher than industrial competitors Honeywell, United Technologies and Eaton at 2.07%, 2.25% and 3.48% respectively.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366164-ge-plans-health-spinoff-baker-hughes-stake-sale\" target=\"_blank\">GE plans health spinoff, Baker Hughes stake sale</a> (Jun. 26 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366249\" data-linked=\"Reduction coming to aggregate GE dividend\" data-tweet=\"$GE - Reduction coming to aggregate GE dividend https://seekingalpha.com/news/3366249-reduction-coming-to-aggregate-ge-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3366249-reduction-coming-to-aggregate-ge-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366246\" data-ts=\"1530020989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGX\" target=\"_blank\">AGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366246-argan-soars-on-subsidiary-power-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argan soars on subsidiary power project</a></h4><ul><li>Gemma Power Systems, a wholly owned subsidiary of Argan (<a href='https://seekingalpha.com/symbol/AGX' title='Argan, Inc.'>AGX</a> <font color='green'>+14.2%</font>), and Chickahominy Power, have <a href=\"https://finance.yahoo.com/news/gemma-power-systems-balico-enter-121500809.html\" target=\"_blank\">entered</a> into an Engineering, Procurement and Construction services contract to construct the Chickahominy Power Station.</li><li>The 1,600 MW state-of-the-art natural gas-fired power plant will be located in Charles City County, Virginia.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366246\" data-linked=\"Argan soars on subsidiary power project\" data-tweet=\"$AGX - Argan soars on subsidiary power project https://seekingalpha.com/news/3366246-argan-soars-on-subsidiary-power-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3366246-argan-soars-on-subsidiary-power-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366235\" data-ts=\"1530019723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366235-puma-biotechplus-27-europe-looks-likely-to-approve-breast-cancer-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Puma Biotech +27% as Europe looks likely to approve breast cancer drug</a></h4><ul>     <li>Puma Biotechnology (NYSE:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) <font color='green'>+27.2%</font> premarket after saying a committee of the European Medicines Agency <a href=\"https://seekingalpha.com/pr/17201740-puma-biotechnology-announces-results-chmp-reexamination-maa-neratinib-extended-adjuvant\" target=\"_blank\">adopted a positive trend vote</a> recommending marketing approval of neratinib for the extended adjuvant treatment of early stage HER2-positive hormone receptor positive breast cancer.</li>     <li>The decision follows a re-examination of a negative opinion announced by the committee in February; Puma says the committee plans to hold a final vote at its next meeting.</li>     <li><a href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm567309.htm\" target=\"_blank\">Last year</a>, the FDA approved neratinib in the U.S.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366235\" data-linked=\"Puma Biotech +27% as Europe looks likely to approve breast cancer drug\" data-tweet=\"$PBYI - Puma Biotech +27% as Europe looks likely to approve breast cancer drug https://seekingalpha.com/news/3366235-puma-biotechplus-27-europe-looks-likely-to-approve-breast-cancer-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/3366235-puma-biotechplus-27-europe-looks-likely-to-approve-breast-cancer-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366234\" data-ts=\"1530019601\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPOT\" target=\"_blank\">SPOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366234-spotifyplus-2_4-barclays-joins-bulls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spotify +2.4% as Barclays joins bulls</a></h4><ul>   <li>Spotify (NYSE:<a href='https://seekingalpha.com/symbol/SPOT' title='Spotify'>SPOT</a>) is <font color='green'>up 2.4%</font> premarket after an initiation at Overweight by Barclays.</li>    <li>Maybe it's not Netflix, analyst Ross Sandler says (<a href=\"https://seekingalpha.com/news/3364031-deutsche-bank-spotify-netflix-2_0\" target=\"_blank\">joining Deutsche Bank</a> in that assessment), but it is a \"recipe for market cap accretion in consumer Internet\" with significant potential for margin expansion with ad revenue ramping up. (h/t Bloomberg)</li>    <li>It's got less pricing power than a Netflix, though, with only a little over half its population on paid plans.</li>    <li>Shares are <font color='green'>up 14.3%</font> in 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366234\" data-linked=\"Spotify +2.4% as Barclays joins bulls\" data-tweet=\"$SPOT - Spotify +2.4% as Barclays joins bulls https://seekingalpha.com/news/3366234-spotifyplus-2_4-barclays-joins-bulls?source=tweet\" data-url=\"https://seekingalpha.com/news/3366234-spotifyplus-2_4-barclays-joins-bulls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366233\" data-ts=\"1530019513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIO\" target=\"_blank\">XBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366233-premarket-losers-of-9-05-6-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (6/26/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a>&nbsp;<font color='red'>-22%</font>&nbsp;retreating after yesterday's gain.</li>     <li><a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3366209-achaogens-zemdri-antibiotic-approved-fda-urinary-tract-infections\" target=\"_blank\">approved</a> by FDA for urinary tract infections.</li>     <li><a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a>&nbsp;<font color='red'>-11%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3366186-senseonics-announces-pricing-public-offering-common-stock\" target=\"_blank\">pricing</a> of public offering of common stock.</li>     <li><a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a>&nbsp;<font color='red'>-7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a>&nbsp;<font color='red'>-6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3366165-heron-therapeutics-announces-pricing-public-offering-common-stock\" target=\"_blank\">pricing</a> of public offering of common stock.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366233\" data-linked=\"Premarket Losers as of 9:05 am (6/26/2018)\" data-tweet=\"$XBIO $XBIO $AKAO - Premarket Losers as of 9:05 am (6/26/2018) https://seekingalpha.com/news/3366233-premarket-losers-of-9-05-6-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366233-premarket-losers-of-9-05-6-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366232\" data-ts=\"1530019256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIT\" target=\"_blank\">WIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366232-nomura-steps-off-wipro-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura steps off Wipro sidelines</a></h4><ul><li>        Nomura upgrades Wipro (NYSE:<a href='https://seekingalpha.com/symbol/WIT' title='Wipro Limited'>WIT</a>) from Reduce to Neutral.</li><li>               Source: Briefing.com.&nbsp;</li><li>               Wipro shares are<font color='red'> down 3.8%</font>&nbsp;premarket to $4.60.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366232\" data-linked=\"Nomura steps off Wipro sidelines\" data-tweet=\"$WIT - Nomura steps off Wipro sidelines https://seekingalpha.com/news/3366232-nomura-steps-off-wipro-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3366232-nomura-steps-off-wipro-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366231\" data-ts=\"1530019113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEE\" target=\"_blank\">LEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366231-premarket-gainers-of-9-05-06-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (06/26/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/LEE' title='Lee Enterprises, Incorporated'>LEE</a> <font color='green'>+46%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3366184-lee-enterprises-skies-42-percent-deal-berkshire\" target=\"_blank\">deal</a> with Berkshire.</li>     <li><a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a> <font color='green'>+44%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3366217-achieve-life-sciences-plus-47-percent-results-smoking-cessation-aid-studies\" target=\"_blank\">results</a> of smoking cessation aid studies.</li>     <li><a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+18%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17201652-avinger-announces-successful-treatment-first-patients-next-generation-pantheris-several\" target=\"_blank\">successful</a> treatment of first patients with next-generation pantheris in several centers throughout the US.</li>     <li><a href='https://seekingalpha.com/symbol/SPPI' title='Spectrum Pharmaceuticals, Inc.'>SPPI</a> <font color='green'>+17%&nbsp;</font>on sale <a href=\"https://seekingalpha.com/news/3366201-spectrum-pharma-plus-21-percent-sale-chatter\" target=\"_blank\">chatter</a>.</li>     <li><a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='green'>+12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3366222-infinity-pharmaceuticals-plus-12-percent-collaboration-pact-arcus\" target=\"_blank\">collaboration</a> pact with Arcus.</li>     <li>ITUS <font color='green'>+11%</font>&nbsp;on&nbsp;status <a href=\"https://seekingalpha.com/pr/17201437-itus-accelerates-schedule-car-t-therapy-provides-update\" target=\"_blank\">update</a> and accelerated development timeline for its CAR T therapy.</li>     <li><a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma'>LIFE</a> <font color='green'>+9%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17200452-mtbc-joins-russell-microcap-index\" target=\"_blank\">joining</a> Russell microcap index.</li>     <li><a href='https://seekingalpha.com/symbol/BWP' title='Boardwalk Pipeline Partners, LP'>BWP</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17200359-sophiris-bio-reports-top-line-interim-safety-biopsy-findings-phase-2b-clinical-trial\" target=\"_blank\">top-line</a> interim safety and biopsy data following a single administration of topsalysin from its ongoing open-label, Phase 2b clinical trial.</li>     <li><a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color='green'>+7%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3366160-lennar-eps-1_58\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17201172-foresight-signs-memorandum-understanding-leading-car-importer-israel-first-sales-eyes-ontm\" target=\"_blank\">signing</a> of a non-binding memorandum of understanding with a direct importer of several leading vehicle manufacturers to&nbsp;Israel.</li>     <li><a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='green'>+7%</font>&nbsp;on health <a href=\"https://seekingalpha.com/news/3366164-ge-plans-health-spinoff-baker-hughes-stake-sale\" target=\"_blank\">spinoff</a>, Baker Hughes stake sale.</li>     <li><a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a> <font color='green'>+5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3366126-exel-plus-5_4-percent-move-midcap-400-cprt-s-and-p-500\" target=\"_blank\">move</a> to MidCap 400; CPRT to S&amp;P 500.</li>     <li><a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+5%</font>&nbsp;after Epidiolex <a href=\"https://seekingalpha.com/news/3366224-gw-pharma-plus-5-percent-day-epidiolex-nod\" target=\"_blank\">nod</a>.</li>     <li><a href='https://seekingalpha.com/symbol/TAL' title='TAL Education Group'>TAL</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366231\" data-linked=\"Premarket Gainers as of 9:05 am (06/26/2018)\" data-tweet=\"$LEE $LEE $ACHV - Premarket Gainers as of 9:05 am (06/26/2018) https://seekingalpha.com/news/3366231-premarket-gainers-of-9-05-06-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366231-premarket-gainers-of-9-05-06-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366230\" data-ts=\"1530019079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366230-jinkosolarminus-5-premarket-after-wide-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JinkoSolar -5% premarket after wide earnings miss</a></h4><ul>     <li>JinkoSolar (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color='red'>-5.4%</font> premarket after <a href=\"https://seekingalpha.com/news/3366172-jinkosolar-holding-eps-0_048\" target=\"_blank\">Q1 earnings</a> come in far below expectations and revenues fall 13% Y/Y to $728M.</li>     <li>JKS says Q1 gross margin rose to 14.4% from 11.6% in the previous quarter, helped by lower polysilicon prices and the further optimization of manufacturing costs as a result of continued technological improvement and reduced OEM usage.</li>     <li>JKS <a href=\"https://www.pv-tech.org/news/jinkosolar-reiterates-11.5gw-to-12gw-of-module-shipments-in-2018\" target=\"_blank\">reiterates previous guidance</a> for PV module shipments of&nbsp;11.5-12 GW for FY 2018, although Q1 shipments of 2.015 GW fell 18.8% Q/Q and 2.6% Y/Y; for Q2, JKS estimates total solar module shipments of 2.4-2.5 GW.</li>     <li>\"We believe the Chinese government's new policies to have relatively limited impact on our operations over the short term, and we remain confident in our future business prospects and the long-term growth of the industry overall,\" the company says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366230\" data-linked=\"JinkoSolar -5% premarket after wide earnings miss\" data-tweet=\"$JKS - JinkoSolar -5% premarket after wide earnings miss https://seekingalpha.com/news/3366230-jinkosolarminus-5-premarket-after-wide-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3366230-jinkosolarminus-5-premarket-after-wide-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366228\" data-ts=\"1530018549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGM\" target=\"_blank\">MGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366228-mgm-down-1_6-on-goldman-downgrade-wyndham-upgraded-alongside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MGM down 1.6% on Goldman downgrade; Wyndham upgraded alongside</a></h4><ul><li>Goldman throws in the towel on MGM Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>), pulling the name from its Conviction List and downgrading to Neutral from Buy.</li><li>While business in Vegas looks good, delays at Park MGM and slower-than-hoped recovery&nbsp; at Mandalay Bay are weighing on MGM, says analyst Stephen Grambling. There's also new competition coming in Atlantic City with the Ocean Resort Casino opening in a few days.</li><li>Wyndham Hotels (NYSE:<a href='https://seekingalpha.com/symbol/WH' title='Wyndham Hotels & Resorts Inc'>WH</a>), meanwhile replaces MGM on the Conviction List, with Grambling noting La Quinta growth, chain scale synergies, and renovated hotels. The recently completed spinoff, says Grambling, should lead to a re-rating for WH's valuation.</li><li>Source: Bloomberg</li><li>MGM&nbsp;<font color='red'>-1.6%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366228\" data-linked=\"MGM down 1.6% on Goldman downgrade; Wyndham upgraded alongside\" data-tweet=\"$MGM $MGM $WH - MGM down 1.6% on Goldman downgrade; Wyndham upgraded alongside https://seekingalpha.com/news/3366228-mgm-down-1_6-on-goldman-downgrade-wyndham-upgraded-alongside?source=tweet\" data-url=\"https://seekingalpha.com/news/3366228-mgm-down-1_6-on-goldman-downgrade-wyndham-upgraded-alongside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366224\" data-ts=\"1530017949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366224-gw-pharmaplus-5-day-after-epidiolex-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GW Pharma +5% day after Epidiolex nod</a></h4><ul><li>GW Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>)<font color='red'> slid 4.3%</font>&nbsp;yesterday despite the FDA for the first time <a href=\"https://seekingalpha.com/news/3366068-fda-approves-first-cannabis-based-drug\" target=\"_blank\">approving a drug derived</a> from marijuana - the company's&nbsp;Epidiolex to treat two rare forms of epilepsy.</li><li>Goldman and BofA are among those with positive notes out today. Goldman reiterates its Buy rating, noting no adjunctive therapy requirement for the label. The team's $188 price target suggests&nbsp;<font color='green'>30% upside</font>&nbsp;from yesterday's close.</li><li>Shares&nbsp;<font color='green'>up 5%</font>&nbsp;premarket to $152.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366224\" data-linked=\"GW Pharma +5% day after Epidiolex nod\" data-tweet=\"$GWPH - GW Pharma +5% day after Epidiolex nod https://seekingalpha.com/news/3366224-gw-pharmaplus-5-day-after-epidiolex-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3366224-gw-pharmaplus-5-day-after-epidiolex-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366223\" data-ts=\"1530017778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMR\" target=\"_blank\">IMMR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366223-immersionminus-1_8-on-dougherty-downgrade-due-to-lower-license-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immersion -1.8% on Dougherty downgrade due to lower license estimates</a></h4><ul><li>        Dougherty downgrades Immersion (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMR' title='Immersion Corporation'>IMMR</a>) from Buy to Neutral.</li><li>               Analyst Charles Anderson thinks Apple&rsquo;s license of certain patents is closer to $10M/year than the $20M previously estimated.&nbsp;</li><li>               Anderson suspends his $14 price target as current levels strike him as fully valued.&nbsp;</li><li>               The analyst analyzed other licensing opportunities and saw a path for annual average revenue of over $75M and EPS of $1 or more. But he also thinks a &ldquo;sale of the company probably makes sense now that the IP is proven via Apple&rsquo;s license.&rdquo;&nbsp;</li><li>               Source: Bloomberg First Word.&nbsp;</li><li>                  Immersion shares are&nbsp;<font color='red'>down 1.8%</font>&nbsp;premarket to $15.49.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3366223\" data-linked=\"Immersion -1.8% on Dougherty downgrade due to lower license estimates\" data-tweet=\"$IMMR - Immersion -1.8% on Dougherty downgrade due to lower license estimates https://seekingalpha.com/news/3366223-immersionminus-1_8-on-dougherty-downgrade-due-to-lower-license-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3366223-immersionminus-1_8-on-dougherty-downgrade-due-to-lower-license-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366222\" data-ts=\"1530017526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFI\" target=\"_blank\">INFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366222-infinity-pharmaceuticalsplus-12-on-collaboration-pact-arcus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinity Pharmaceuticals +12% on collaboration pact with Arcus</a></h4><ul><li>Infinity Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a>)&nbsp;<font color='green'>jumps 12%</font>&nbsp;in premarket trading after announcing an agreement with Arcus Biosciences (NYSE:<a href='https://seekingalpha.com/symbol/RCUS' title='Arcus Biosciences'>RCUS</a>) to evaluate two triple combination therapies in selected tumor types that typically show minimal response to checkpoint inhibition monotherapy.</li><li>The company's will evaluate Infinity's IPI-549 in combination with Arcus's AB928 dual adenosine receptor antagonist and AB122, Arcus's anti-PD-1 antibody, as well as IPI-549 in combination with AB928 and chemotherapy in patients with triple negative breast cancer or ovarian cancer in four separate cohorts.</li><li>The four cohorts will be incorporated into Arcus's recently initiated Phase 1/1b trial to evaluate AB928 combinations in TNBC and ovarian cancer.</li><li>Under the terms of the agreement, Infinity and Arcus will share equally expenses related to the four triple-combination cohorts to evaluate the safety and activity of IPI-549 + AB928 + AB122 and IPI-549 + AB928 + chemotherapy. Each of the four triple-combination cohorts will enroll approximately 15 patients. Topline data from these studies are expected in 2019.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17201637-arcus-biosciences-infinity-pharmaceuticals-announce-clinical-collaboration-evaluate-lead\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3311085-infinity-pharmas-lead-candidate-ipiminus-549-shows-shows-positive-effect-early-stage\" target=\"_blank\">Infinity Pharma's lead candidate IPI-549 shows shows positive effect in early-stage monotherapy study but shares down 16% premarket</a> (Nov. 10, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366222\" data-linked=\"Infinity Pharmaceuticals +12% on collaboration pact with Arcus\" data-tweet=\"$INFI $INFI $RCUS - Infinity Pharmaceuticals +12% on collaboration pact with Arcus https://seekingalpha.com/news/3366222-infinity-pharmaceuticalsplus-12-on-collaboration-pact-arcus?source=tweet\" data-url=\"https://seekingalpha.com/news/3366222-infinity-pharmaceuticalsplus-12-on-collaboration-pact-arcus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366220\" data-ts=\"1530017209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366220-nvidia-1_4-after-benchmark-new-buy-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia 1.4% after Benchmark New Buy rating</a></h4><ul><li>        Benchmark <a href=\"https://www.marketwatch.com/story/nvidia-stock-gains-after-benchmark-starts-coverage-with-buy-rating-2018-06-26\" target=\"_blank\">rates</a> Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) a New Buy with a $280 price target, a 17% upside to yesterday&rsquo;s close.</li><li>               Analyst Mike Burton: &ldquo;While a lofty valuation gives us some pause, we expect the company to deliver upside to estimates with demand driven by sustainable growth in its core markets in the data center and the upcoming Volta product cycle for consumer GPUS (which we expect in 2H18).&rdquo;&nbsp;</li><li>               Burton thinks the potential cryptocurrency mining downside is &ldquo;relatively contained.&rdquo;&nbsp;</li><li>               The analyst also initiated coverage on AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) and Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) and gave both Hold ratings.&nbsp;</li><li>               Nvidia shares are&nbsp;<font color='green'>up 1.4%</font>&nbsp;premarket to $242.38.&nbsp;</li><li>               AMD shares are&nbsp;<font color='green'>up 1.7%</font>&nbsp;to $15.36.&nbsp;</li><li>               Intel shares are&nbsp;<font color='red'>down 1.8%</font>&nbsp;to $49.80.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366191-intel-minus-1_8-percent-bernstein-moves-underperform\" target=\"_blank\">Intel -1.8% after Bernstein moves to Underperform</a> (June 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366220\" data-linked=\"Nvidia 1.4% after Benchmark New Buy rating\" data-tweet=\"$NVDA $NVDA $AMD - Nvidia 1.4% after Benchmark New Buy rating https://seekingalpha.com/news/3366220-nvidia-1_4-after-benchmark-new-buy-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3366220-nvidia-1_4-after-benchmark-new-buy-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366217\" data-ts=\"1530016563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHV\" target=\"_blank\">ACHV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366217-achieve-life-sciencesplus-47-on-results-of-smoking-cessation-aid-studies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achieve Life Sciences +47% on results of smoking cessation aid studies</a></h4><ul><li>Achieve Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a>) <font color='green'>+47.3%</font> premarket after announcing <a href=\"https://seekingalpha.com/pr/17201220-achieve-announces-positive-cytisine-data-demonstrating-clinically-significant-drug-drug\" target=\"_blank\">positive results</a> from a series of drug metabolism, drug-drug  interaction and transporter studies with cytisine, its product  candidate being evaluated as an aid to smoking cessation.</li><li>ACHV says the study showed that cytisine has no clinically significant  interaction with any of the hepatic enzymes commonly responsible for  drug metabolism nor clinically significant interaction with drug  transporters.</li><li>The findings suggest cytisine may be administered with other  medications without the need to modify the dose of the co-administered  drug, the company says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366217\" data-linked=\"Achieve Life Sciences +47% on results of smoking cessation aid studies\" data-tweet=\"$ACHV - Achieve Life Sciences +47% on results of smoking cessation aid studies https://seekingalpha.com/news/3366217-achieve-life-sciencesplus-47-on-results-of-smoking-cessation-aid-studies?source=tweet\" data-url=\"https://seekingalpha.com/news/3366217-achieve-life-sciencesplus-47-on-results-of-smoking-cessation-aid-studies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366215\" data-ts=\"1530016460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MELI\" target=\"_blank\">MELI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366215-mercadolibreplus-1_4-on-keybanc-upgrade-21-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MercadoLibre +1.4% on KeyBanc upgrade with 21% upside</a></h4><ul><li>           KeyBanc <a href=\"https://www.streetinsider.com/Analyst+Comments/KeyBanc+Upgrades+MercadoLibre+%28MELI%29+to+Overweight/14341591.html\" target=\"_blank\">upgrades</a> MercadoLibre (NASDAQ:<a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a>) from Sector Weight to Overweight with a $350 price target, a 21% upside to yesterday&rsquo;s close. </li><li>           MercadoLibre shares are&nbsp;<font color='green'>up 1.4%</font>&nbsp;premarket to $292.36. <br />&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3366215\" data-linked=\"MercadoLibre +1.4% on KeyBanc upgrade with 21% upside\" data-tweet=\"$MELI - MercadoLibre +1.4% on KeyBanc upgrade with 21% upside https://seekingalpha.com/news/3366215-mercadolibreplus-1_4-on-keybanc-upgrade-21-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3366215-mercadolibreplus-1_4-on-keybanc-upgrade-21-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366208\" data-ts=\"1530015456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366208-akamai-trims-outlook-shares-down-2_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai trims outlook; shares down 2.5%</a></h4><ul><li>At issue is the stronger dollar. It's causing revenue headwinds of $3M in revenue and a penny per share to the Q2 outlook issued on April 30.</li><li>That outlook: Revenue of $658M-$670M and non-GAAP income of $0.79-$0.83 per share. It's now seen at $658M-$663M and $0.79-$0.81.</li><li>Full-year is better. Thanks to improved operating margins, company now sees non-GAAP EPS of $3.20-$3.30 per share vs. $3.15-$3.25 previously.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17201537-b-akamai-b-updates-second-quarter-fiscal-year-2018-financial-guidance-conjunction-analyst-day\" target=\"_blank\">Press Release</a></li><li><a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>&nbsp;<font color='red'>-2.5%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3366208\" data-linked=\"Akamai trims outlook; shares down 2.5%\" data-tweet=\"$AKAM - Akamai trims outlook; shares down 2.5% https://seekingalpha.com/news/3366208-akamai-trims-outlook-shares-down-2_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3366208-akamai-trims-outlook-shares-down-2_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366201\" data-ts=\"1530014098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPPI\" target=\"_blank\">SPPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366201-spectrum-pharmaplus-21-on-sale-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spectrum Pharma +21% on sale chatter</a></h4><ul><li>No details are available, but Bloomberg reports <a href=\"https://www.streetinsider.com/Hot+M+and+A/Spectrum+Pharma+%28SPPI%29+Said+to+Explore+Sale+Amid+Takeover+Interest+-+Bloomberg/14341946.html\" target=\"_blank\">takeover interest in </a>Spectrum Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SPPI' title='Spectrum Pharmaceuticals, Inc.'>SPPI</a>) has the company mulling a sale.</li><li>Shares&nbsp;<font color='green'>+21.4%&nbsp;</font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366201\" data-linked=\"Spectrum Pharma +21% on sale chatter\" data-tweet=\"$SPPI - Spectrum Pharma +21% on sale chatter https://seekingalpha.com/news/3366201-spectrum-pharmaplus-21-on-sale-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3366201-spectrum-pharmaplus-21-on-sale-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366198\" data-ts=\"1530013745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366198-lam-researchplus-2_3-ubs-steps-off-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lam Research +2.3% as UBS steps off sidelines</a></h4><ul><li>        UBS <a href=\"https://www.streetinsider.com/Hot+Upgrades/UBS+Upgrades+Lam+Research+%28LRCX%29+to+Buy/14342211.html\" target=\"_blank\">upgrades</a> Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) from Neutral to Buy.</li><li>                  Lam Research shares are&nbsp;<font color='green'>up 2.3%</font>&nbsp;premarket to $175.&nbsp;&nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3366198\" data-linked=\"Lam Research +2.3% as UBS steps off sidelines\" data-tweet=\"$LRCX - Lam Research +2.3% as UBS steps off sidelines https://seekingalpha.com/news/3366198-lam-researchplus-2_3-ubs-steps-off-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3366198-lam-researchplus-2_3-ubs-steps-off-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366196\" data-ts=\"1530013560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEN\" target=\"_blank\">LEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366196-lennar-gains-8-q2-reflects-first-full-quarter-of-calatlantic-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lennar gains 8% as Q2 reflects first full quarter of CalAtlantic buy</a></h4><ul><li>Lennar (NYSE:<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a>)&nbsp;<font color='green'>+8%</font>&nbsp;in premarket trading after reporting first full quarter including CalAtlantic acquisition.</li><li>Q2 deliveries up 57% Y/Y to 12,095 homes; new orders up 62% to 14,440 homes; new orders dollar value of $6.0B, up 79%.</li><li>Backlog of 19,622 homes, up 92%; backlog dollar value of $8.6B, up 114%.</li><li>\"Concerns about rising interest rates and construction costs have been offset by low unemployment and increasing wages, combined with short supply based on years of underproduction of new homes,\" says Chairman Stuart Miller.</li><li>Q2 operating margin on home sales of 12.9%, excluding backlog/construction in progress write-up related to purchase accounting, vs. 12.1%. Including writeup, the margin is 8.2%.</li><li>Reduced debt levels by $1.1B during the quarter.</li><li>Q2 net earnings $310.3M, or 94 cents a share, including 58 cents a share related to backlog/construction in progress write-up related to purchase accounting and 6 cents a share related to acquisition and integration costs.</li><li>Q2 total revenue $5.46B vs. $3.26B Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366160-lennar-eps-1_58\" target=\"_blank\">Lennar EPS of $1.58</a> (June 26)</li><li>Source: <a href=\"https://seekingalpha.com/pr/17201241-lennar-reports-second-quarter-eps-0_94\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3366196\" data-linked=\"Lennar gains 8% as Q2 reflects first full quarter of CalAtlantic buy\" data-tweet=\"$LEN $LEN.B - Lennar gains 8% as Q2 reflects first full quarter of CalAtlantic buy https://seekingalpha.com/news/3366196-lennar-gains-8-q2-reflects-first-full-quarter-of-calatlantic-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3366196-lennar-gains-8-q2-reflects-first-full-quarter-of-calatlantic-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366195\" data-ts=\"1530013436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOMO\" target=\"_blank\">MOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366195-momominus-2_2-on-planned-senior-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Momo -2.2% on planned senior note offering</a></h4><ul><li>        Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a>) <a href=\"https://seekingalpha.com/pr/17201284-momo-inc-announces-proposed-offering-us-650-million-convertible-senior-notes\" target=\"_blank\">plans to offer</a> $650M in convertible senior notes due 2025. Initial purchasers will have a 30-day option to buy up to an additional $100M.</li><li>               The company will use the net proceeds to repay the $300M bank loan facility entered into in May to partially finance the Tantan acquisition, pay the outstanding consideration for Tantan, and to invest in business development initiatives for the Momo platform.</li><li>               Momo shares are&nbsp;<font color='red'>down 2.2%</font>&nbsp;premarket to $47.10.&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366195\" data-linked=\"Momo -2.2% on planned senior note offering\" data-tweet=\"$MOMO - Momo -2.2% on planned senior note offering https://seekingalpha.com/news/3366195-momominus-2_2-on-planned-senior-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3366195-momominus-2_2-on-planned-senior-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366191\" data-ts=\"1530012865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366191-intelminus-1_8-after-bernstein-moves-to-underperform-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel -1.8% after Bernstein moves to Underperform (update)</a></h4><ul><li>Bernstein <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Bernstein+Downgrades+Intel+%28INTC%29+to+Underperform/14341833.html\" target=\"_blank\">downgrades</a> Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) from Market Perform to Underperform.</li><li>Intel shares are&nbsp;<font color='red'>down 1.8%</font>&nbsp;premarket to $49.80.</li><li>        Update with <a href=\"https://www.cnbc.com/2018/06/26/intel-shares-slide-after-bernstein-downrgade.html\" target=\"_blank\">more details</a>:</li><li>               Analyst Stacy Rasgon says that it&rsquo;s &ldquo;becoming increasingly apparent that the structural issues we have promulgated for years are becoming ever obvious to investors.&rdquo;&nbsp;</li><li>               Rasgon thinks the uncertainty around the CEO change provides &ldquo;some protection from forward revisions and that EPS growth will slow into 2019 as &ldquo;compares get harder and structural issues build.&nbsp;</li><li>Price target is slashed from $54 to $42, a 17% upside to yesterday's close.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366191\" data-linked=\"Intel -1.8% after Bernstein moves to Underperform (update)\" data-tweet=\"$INTC - Intel -1.8% after Bernstein moves to Underperform (update) https://seekingalpha.com/news/3366191-intelminus-1_8-after-bernstein-moves-to-underperform-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3366191-intelminus-1_8-after-bernstein-moves-to-underperform-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366190\" data-ts=\"1530012436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366190-micronplus-2_1-after-ubs-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron +2.1% after UBS upgrade</a></h4><ul><li>        UBS upgrades Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) from Sell to Neutral.</li><li>        Source: Briefing.com. &nbsp;</li><li>        Micron shares are&nbsp;<font color='green'>up 2.1%</font>&nbsp;premarket to $54.28.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366190\" data-linked=\"Micron +2.1% after UBS upgrade\" data-tweet=\"$MU - Micron +2.1% after UBS upgrade https://seekingalpha.com/news/3366190-micronplus-2_1-after-ubs-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3366190-micronplus-2_1-after-ubs-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>195&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366187\" data-ts=\"1530012162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDS\" target=\"_blank\">FDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366187-factsetplus-11_7-on-q3-beats-raised-eps-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FactSet +11.7% on Q3 beats, raised EPS guidance</a></h4><ul><li>        FactSet Research Systems (NYSE:<a href='https://seekingalpha.com/symbol/FDS' title='FactSet Research Systems Inc.'>FDS</a>) gains 11.7% premarket on Q3 results that beat EPS and revenue estimates with a 9% Y/Y growth.</li><li>               FY18 guidance has in-line revenue from $1.34B to $1.36B (consensus: $1.35B) and raised in-line EPS from $8.37 to $8.62 (consensus: $8.48; was: $8.35 to $8.55).&nbsp;</li><li>               Earnings call is scheduled for 11 AM Eastern with a webcast available <a href=\"https://seekingalpha.com/pr/17201336-factset-reports-strong-revenue-eps-growth-third-quarter-2018\" target=\"_blank\">here</a>.&nbsp;</li><li>                  <a href=\"https://investor.factset.com/investors/audiocasts/default.aspx\" target=\"_blank\">Press release</a>.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3366180-factset-research-systems-beats-0_05-revenue-line\" target=\"_blank\">FactSet Research Systems beats by $0.05,  revenue in-line</a> (June 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366187\" data-linked=\"FactSet +11.7% on Q3 beats, raised EPS guidance\" data-tweet=\"$FDS - FactSet +11.7% on Q3 beats, raised EPS guidance https://seekingalpha.com/news/3366187-factsetplus-11_7-on-q3-beats-raised-eps-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3366187-factsetplus-11_7-on-q3-beats-raised-eps-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366185\" data-ts=\"1530012028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366185-netflix-gains-another-wall-street-bull-shares-up-1_7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix gains another Wall Street bull; shares up 1.7% premarket</a></h4><ul><li>Imperial Capital analyst David Miller starts coverage with an Outperform rating and Street-high price target of $503 suggesting another 30% upside in the red-hot stock.</li><li>He notes Netflix's (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) $7.99 per month basic streaming price is less than the $8.25 charged by Amazon Prime, while offering 20% more TV series.</li><li>Operating leverage is on tap this year, says Miller, thanks to enough scale and no need so spend so highly on marketing and tech/development.</li><li>Shares&nbsp;<font color='green'>+1.7%</font>&nbsp;premarket to $391.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3366185\" data-linked=\"Netflix gains another Wall Street bull; shares up 1.7% premarket\" data-tweet=\"$NFLX - Netflix gains another Wall Street bull; shares up 1.7% premarket https://seekingalpha.com/news/3366185-netflix-gains-another-wall-street-bull-shares-up-1_7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3366185-netflix-gains-another-wall-street-bull-shares-up-1_7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366184\" data-ts=\"1530011768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEE\" target=\"_blank\">LEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366184-lee-enterprises-skies-42-on-deal-berkshire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lee Enterprises skies 42% on deal with Berkshire</a></h4><ul><li>Lee Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/LEE' title='Lee Enterprises, Incorporated'>LEE</a>) agrees to manage the newspaper and digital operations in 30 markets for Berkshire Hathaway (<a href='https://seekingalpha.com/symbol/BRK.A' title='Berkshire Hathaway A'>BRK.A</a>, <a href='https://seekingalpha.com/symbol/BRK.B' title='Berkshire Hathaway B'>BRK.B</a>).</li><li>Warren Buffett: \"The challenges in publishing are clear ...&nbsp;Lee Enterprises&rsquo; growth in digital market share and revenue has outpaced the industry.\"</li><li>Lee is to receive an annual fee of $5M, plus a significant percentage of profits over benchmarks.</li><li>A <a href=\"http://tinyurl.com/Leecall\" target=\"_blank\">conference call </a>is set for 11 ET.</li><li>LEE&nbsp;<font color='green'>+40.2%</font>&nbsp;premarket</li><li>Source: <a href=\"https://seekingalpha.com/pr/17201279-b-lee-b-enterprises-will-manage-berkshire-hathaway-newspaper-digital-operations-30-markets\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3366184\" data-linked=\"Lee Enterprises skies 42% on deal with Berkshire\" data-tweet=\"$LEE $LEE $BRK.A - Lee Enterprises skies 42% on deal with Berkshire https://seekingalpha.com/news/3366184-lee-enterprises-skies-42-on-deal-berkshire?source=tweet\" data-url=\"https://seekingalpha.com/news/3366184-lee-enterprises-skies-42-on-deal-berkshire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366164\" data-ts=\"1530008185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366164-ge-plans-health-spinoff-baker-hughes-stake-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE plans health spinoff, Baker Hughes stake sale</a></h4><ul><li>Breaking up is hard to do, but it's turning into a reality for General Electric (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a>).</li><li>According to the <i>WSJ</i>, the once industrial conglomerate <a href=\"https://www.wsj.com/articles/ge-to-spin-off-health-care-business-in-latest-revamp-1530005401?mod=searchresults&amp;page=1&amp;pos=1\" target=\"_blank\">plans</a> to spin off its healthcare business and unload ownership in its oil services company Baker Hughes (NYSE:<a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a>).</li><li>CEO John Flannery's final turnaround plan, expected to be presented to investors today, focuses around GE's power, aviation and renewable-energy divisions.</li><li>GE <font color='green'>+1.7% </font>premarket</li><li><strong>Update: </strong>The stock is now <font color='green'>up almost 5</font><font color='green'>%</font> to $13.37/share. GE has confirmed the report , stating its $20B divestiture target (including distributed power, industrial solutions, value-based care and transportation) is substantially complete. GE also expects to maintain its current dividend until GE Healthcare is established as an independent entity.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366015-ge-confirms-deal-sell-industrial-engines-unit-advent-3_25b\" target=\"_blank\">GE confirms deal to sell industrial engines unit to Advent for $3.25B</a> (Jun. 25 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366164\" data-linked=\"GE plans health spinoff, Baker Hughes stake sale\" data-tweet=\"$GE $GE $BKR - GE plans health spinoff, Baker Hughes stake sale https://seekingalpha.com/news/3366164-ge-plans-health-spinoff-baker-hughes-stake-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3366164-ge-plans-health-spinoff-baker-hughes-stake-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>154&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}